BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wiesner RH, Demetris AJ, Belle SH, Seaberg EC, Lake JR, Zetterman RK, Everhart J, Detre KM. Acute hepatic allograft rejection: incidence, risk factors, and impact on outcome. Hepatology. 1998;28:638-645. [PMID: 9731552 DOI: 10.1002/hep.510280306] [Cited by in Crossref: 360] [Cited by in F6Publishing: 289] [Article Influence: 15.0] [Reference Citation Analysis]
Number Citing Articles
1 Czaja AJ. Understanding the pathogenesis of autoimmune hepatitis. Am J Gastroenterol. 2001;96:1224-1231. [PMID: 11316174 DOI: 10.1111/j.1572-0241.2001.03707.x] [Cited by in Crossref: 89] [Cited by in F6Publishing: 85] [Article Influence: 4.2] [Reference Citation Analysis]
2 Gelson W, Hoare M, Unitt E, Palmer C, Gibbs P, Coleman N, Davies S, Alexander GJ. Heterogeneous inflammatory changes in liver graft recipients with normal biochemistry. Transplantation. 2010;89:739-748. [PMID: 20134396 DOI: 10.1097/tp.0b013e3181c96b32] [Cited by in Crossref: 11] [Cited by in F6Publishing: 1] [Article Influence: 0.9] [Reference Citation Analysis]
3 Raimondo ML, Burroughs AK. Single-Agent Immunosuppression After Liver Transplantation: What is Possible? Drugs 2002;62:1587-97. [DOI: 10.2165/00003495-200262110-00002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
4 Tavabie OD, Colwill M, Adamson R, Mcphail MJ, Bernal W, Jassem W, Prachialias A, Heneghan M, Aluvihare VR, Agarwal K. A ‘real-world’ analysis of risk factors for post liver transplant delirium and the effect on length of stay. European Journal of Gastroenterology & Hepatology 2020;32:1373-80. [DOI: 10.1097/meg.0000000000001661] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 de la Garza RG, Sarobe P, Merino J, Lasarte JJ, D'Avola D, Belsue V, Delgado JA, Silva L, Iñarrairaegui M, Sangro B, Sola JJ, Pardo F, Quiroga J, Herrero JI. Trial of complete weaning from immunosuppression for liver transplant recipients: factors predictive of tolerance. Liver Transpl 2013;19:937-44. [PMID: 23784747 DOI: 10.1002/lt.23686] [Cited by in Crossref: 60] [Cited by in F6Publishing: 57] [Article Influence: 6.7] [Reference Citation Analysis]
6 Kwekkeboom J, Kuijpers MA, Bruyneel B, Mancham S, De Baar-Heesakkers E, Ijzermans JN, Bouma GJ, Zondervan PE, Tilanus HW, Metselaar HJ. Expression of CD80 on Kupffer cells is enhanced in cadaveric liver transplants. Clin Exp Immunol. 2003;132:345-351. [PMID: 12699427 DOI: 10.1046/j.1365-2249.2003.02129.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
7 Kotecha R, Toledo-pereyra LH. Prolonged Cold Ischemia Enhances Alloimmune Response to Liver Grafts. Journal of Surgical Research 2012;176:14-6. [DOI: 10.1016/j.jss.2011.05.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
8 Rodríguez-perálvarez M, De Luca L, Crespo G, Rubin Á, Marín S, Benlloch S, Colmenero J, Berenguer M, Navasa M, Tsochatzis E, De la Mata M. An objective definition for clinical suspicion of T-cell-mediated rejection after liver transplantation. Clin Transplant 2017;31:e13005. [DOI: 10.1111/ctr.13005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
9 Lefkowitch JH. Pathology of the liver. Curr Opin Gastroenterol 1999;15:192-9. [PMID: 17023945 DOI: 10.1097/00001574-199905000-00003] [Reference Citation Analysis]
10 Shindoh J, Akamatsu N, Tanaka T, Kaneko J, Tamura S, Sakamoto Y, Hasegawa K, Sugawara Y, Makuuchi M, Kokudo N. Risk factors for acute liver allograft rejection and their influences on treatment outcomes of rescue therapy in living donor liver transplantation. Clin Transplant 2016;30:880-5. [DOI: 10.1111/ctr.12760] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
11 Fahrner R, Dondorf F, Ardelt M, Settmacher U, Rauchfuss F. Role of NK, NKT cells and macrophages in liver transplantation. World J Gastroenterol 2016; 22(27): 6135-6144 [PMID: 27468206 DOI: 10.3748/wjg.v22.i27.6135] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
12 Kelava T, Turcic P, Markotic A, Ostojic A, Sisl D, Mrzljak A. Importance of genetic polymorphisms in liver transplantation outcomes. World J Gastroenterol 2020; 26(12): 1273-1285 [PMID: 32256016 DOI: 10.3748/wjg.v26.i12.1273] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Langrehr JM, Puhl G, Bahra M, Schmeding M, Spinelli A, Berg T, Schönemann C, Krenn V, Neuhaus P, Neumann UP. Influence of donor/recipient HLA-matching on outcome and recurrence of hepatitis C after liver transplantation. Liver Transpl. 2006;12:644-651. [PMID: 16555324 DOI: 10.1002/lt.20648] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
14 Feng S. Long-term management of immunosuppression after pediatric liver transplantation: is minimization or withdrawal desirable or possible or both? Curr Opin Organ Transplant 2008;13:506-12. [PMID: 19060534 DOI: 10.1097/MOT.0b013e328310b0f7] [Cited by in Crossref: 28] [Cited by in F6Publishing: 7] [Article Influence: 2.2] [Reference Citation Analysis]
15 Gelb B, Feng S. Management of the liver transplant patient. Expert Rev Gastroenterol Hepatol 2009;3:631-47. [PMID: 19929584 DOI: 10.1586/egh.09.58] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
16 Gül-Klein S, Kästner A, Haber PK, Krenzien F, Wabitsch S, Krannich A, Andreou A, Eurich D, Tacke F, Horst D, Pratschke J, Schmelzle M. Recurrence of Hepatocellular Carcinoma After Liver Transplantation is Associated with Episodes of Acute Rejections. J Hepatocell Carcinoma 2021;8:133-43. [PMID: 33777855 DOI: 10.2147/JHC.S292010] [Reference Citation Analysis]
17 Palmer W, Taner C, Keaveny A, Nakhleh R, Nguyen J, Rosser B. Antithymocyte Globulin Use for Corticosteroid Nonresponsive Rejection After Liver Transplantation. Transplantation Proceedings 2018;50:3606-14. [DOI: 10.1016/j.transproceed.2018.09.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Fernandes H, Koneru B, Fernandes N, Hameed M, Cohen MC, Raveche E, Cohen S. Investigation of promoter polymorphisms in the tumor necrosis factor-?? and interleukin-10 genes in liver transplant patients: . Transplantation 2002;73:1886-91. [DOI: 10.1097/00007890-200206270-00006] [Cited by in Crossref: 45] [Cited by in F6Publishing: 42] [Article Influence: 2.3] [Reference Citation Analysis]
19 Knowlton JQ, Taylor AJ, Reichelderfer M, Stang J. Imaging of Biliary Tract Inflammation: An Update. American Journal of Roentgenology 2008;190:984-92. [DOI: 10.2214/ajr.07.3033] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Pei F, Shang K, Jiang B, Wang H, Mei F, Zhang Y, Du J, Zhong H, You J. Clinicopathologic study on complications of orthotopic liver transplantation in 54 patients with chronic hepatitis B viral infection. Hepatol Int 2013;7:468-76. [DOI: 10.1007/s12072-013-9422-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
21 Cholongitas E, Shusang V, Germani G, Tsochatzis E, Raimondo ML, Marelli L, Senzolo M, Davidson BR, Patch D, Rolles K, Burroughs AK. Long-term follow-up of immunosuppressive monotherapy in liver transplantation: tacrolimus and microemulsified cyclosporin: Liver transplantation and calcineurin inhibitors. Clinical Transplantation 2011;25:614-24. [DOI: 10.1111/j.1399-0012.2010.01321.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
22 Moser MA. Options for Induction Immunosuppression in Liver Transplant Recipients: . Drugs 2002;62:995-1011. [DOI: 10.2165/00003495-200262070-00002] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 1.2] [Reference Citation Analysis]
23 Shaik I, Carmody IC, Chen PW. Treatment of Acute and Chronic Rejection. Transplantation of the Liver. Elsevier; 2015. pp. 1317-28. [DOI: 10.1016/b978-1-4557-0268-8.00093-2] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
24 Ziolkowski J, Paczek L, Niewczas M, Senatorski G, Oldakowska-Jedynak U, Wyzgal J, Foroncewicz B, Mucha K, Zegarska J, Nyckowski P, Zieniewicz K, Patkowski W, Krawczyk M, Ziarkiewicz-Wroblewska B, Gornicka B. Acute liver transplant rejection: incidence and the role of high-doses steroids. Transplant Proc 2003;35:2289-91. [PMID: 14529918 DOI: 10.1016/s0041-1345(03)00797-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
25 Gao Z. Seeking Beyond Rejection: An Update on the Differential Diagnosis and a Practical Approach to Liver Allograft Biopsy Interpretation. Advances in Anatomic Pathology 2009;16:97-117. [DOI: 10.1097/pap.0b013e31819946aa] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
26 Germani G, Pleguezuelo M, Villamil F, Vaghjiani S, Tsochatzis E, Andreana L, Burroughs AK. Azathioprine in liver transplantation: a reevaluation of its use and a comparison with mycophenolate mofetil. Am J Transplant. 2009;9:1725-1731. [PMID: 19538488 DOI: 10.1111/j.1600-6143.2009.02705.x] [Cited by in Crossref: 70] [Cited by in F6Publishing: 44] [Article Influence: 5.4] [Reference Citation Analysis]
27 Takakura K, Kiuchi T, Kasahara M, Uryuhara K, Uemoto S, Inomata Y, Tanaka K. Clinical implications of flow cytometry crossmatch with T or B cells in living donor liver transplantation: Cytometry crossmatch with T or B cells. Clin Transplantation 2001;15:309-16. [DOI: 10.1034/j.1399-0012.2001.150502.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 25] [Article Influence: 1.7] [Reference Citation Analysis]
28 Desai M, Neuberger J. Chronic liver allograft dysfunction. Transplant Proc. 2009;41:773-776. [PMID: 19328977 DOI: 10.1016/j.transproceed.2009.01.038] [Cited by in Crossref: 30] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
29 Fairfield C, Penninga L, Powell J, Harrison EM, Wigmore SJ. Glucocorticosteroid-free versus glucocorticosteroid-containing immunosuppression for liver transplanted patients. Cochrane Database Syst Rev 2018;4:CD007606. [PMID: 29630730 DOI: 10.1002/14651858.CD007606.pub4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
30 Burroughs A. Induction immunosuppression for patients who underwent transplantation for cirrhosis caused by hepatitis C? The answer is no! Liver Transplantation 2002;8:S47-9. [DOI: 10.1053/jlts.2002.35853] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
31 Chen CL, Fan ST, Lee SG, Makuuchi M, Tanaka K. Living-donor liver transplantation: 12 years of experience in Asia. Transplantation. 2003;75:S6-11. [PMID: 12589130 DOI: 10.1097/01.tp.0000046533.93621.c7] [Cited by in Crossref: 130] [Cited by in F6Publishing: 24] [Article Influence: 6.8] [Reference Citation Analysis]
32 Zarkhin V, Talisetti A, Li L, Wozniak LJ, McDiarmid SV, Cox K, Esquivel C, Sarwal MM. Expression of soluble HLA-G identifies favorable outcomes in liver transplant recipients. Transplantation. 2010;90:1000-1005. [PMID: 20814356 DOI: 10.1097/tp.0b013e3181f546af] [Cited by in Crossref: 37] [Cited by in F6Publishing: 12] [Article Influence: 3.1] [Reference Citation Analysis]
33 Gelley F, Gámán G, Gerlei Z, Zádori G, Görög D, Kóbori L, Fehérvári I, Schuller J, Szőnyi L, Nagy P, Doros A, Fazakas J, Lengyel G, Schaff Z, Kiss A, Sárváry E, Nemes B. Hepatitis C virus recurrence after liver transplantation in Hungary. Trends over the past 10 years. Orvosi Hetilap 2013;154:1058-66. [DOI: 10.1556/oh.2013.29647] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
34 Balan V, Ruppert K, Demetris AJ, Ledneva T, Duquesnoy RJ, Detre KM, Wei YL, Rakela J, Schafer DF, Roberts JP. Long-term outcome of human leukocyte antigen mismatching in liver transplantation: results of the National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database. Hepatology. 2008;48:878-888. [PMID: 18752327 DOI: 10.1002/hep.22435] [Cited by in Crossref: 69] [Cited by in F6Publishing: 50] [Article Influence: 4.9] [Reference Citation Analysis]
35 Górnicka B, Ziarkiewicz-wróblewska B, Bogdańska M, Ołdakowska-jedynak U, Wróblewski T, Morton M, Ziółkowski J, Pączek L, Krawczyk M, Wasiutyński A. Pathomorphological Features of Acute Rejection in Patients After Orthotopic Liver Transplantation: Own Experience. Transplantation Proceedings 2006;38:221-5. [DOI: 10.1016/j.transproceed.2006.01.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
36 Regev A, Schiff ER. Liver disease in the elderly. Gastroenterol Clin North Am. 2001;30:547-563, x-xi. [PMID: 11432305 DOI: 10.1016/s0889-8553(05)70195-3] [Cited by in Crossref: 46] [Cited by in F6Publishing: 17] [Article Influence: 2.2] [Reference Citation Analysis]
37 Peng M, Li Y, Zhang M, Jiang Y, Xu Y, Tian Y, Peng F, Gong G. Clinical features in different age groups of patients with autoimmune hepatitis. Exp Ther Med. 2014;7:145-148. [PMID: 24348780 DOI: 10.3892/etm.2013.1363] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
38 Ng V, Anand R, Martz K, Fecteau A. Liver Retransplantation in Children: A SPLIT Database Analysis of Outcome and Predictive Factors for Survival: Liver Retransplantation in Children. American Journal of Transplantation 2008;8:386-95. [DOI: 10.1111/j.1600-6143.2007.02056.x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 30] [Article Influence: 3.5] [Reference Citation Analysis]
39 Nguyen TH, Melancon K, Lake J, Payne W, Humar A. Do graft type or donor source affect acute rejection rates after liver transplant: a multivariate analysis: Do graft type or donor source affect acute rejection rates after liver transplant. Clinical Transplantation 2008;22:624-9. [DOI: 10.1111/j.1399-0012.2008.00834.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
40 Das A. Cost-effectiveness of different strategies of cytomegalovirus prophylaxis in orthotopic liver transplant recipients. Hepatology 2000;31:311-7. [DOI: 10.1002/hep.510310208] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
41 Kato H, Usui M, Muraki Y, Okuda M, Nakatani K, Hayasaki A, Ito T, Iizawa Y, Murata Y, Tanemura A, Kuriyama N, Azumi Y, Kishiwada M, Mizuno S, Sakurai H, Isaji S. Intravenous Administration of Tacrolimus Stabilizes Control of Blood Concentration Regardless of CYP3A5 Polymorphism in Living Donor Liver Transplantation: Comparison of Intravenous Infusion and Oral Administration in Early Postoperative Period. Transplant Proc 2018;50:2684-9. [PMID: 30401377 DOI: 10.1016/j.transproceed.2018.03.049] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
42 Sundaram SS, Melin-Aldana H, Neighbors K, Alonso EM. Histologic characteristics of late cellular rejection, significance of centrilobular injury, and long-term outcome in pediatric liver transplant recipients. Liver Transpl 2006;12:58-64. [PMID: 16382471 DOI: 10.1002/lt.20661] [Cited by in Crossref: 40] [Cited by in F6Publishing: 27] [Article Influence: 2.5] [Reference Citation Analysis]
43 Boix-Giner F, Millan O, San Segundo D, Muñoz-Cacho P, Mancebo E, Llorente S, Rafael-Valdivia L, Rimola A, Fábrega E, Mrowiec A, Allende L, Minguela A, Bolarín JM, Paz-Artal E, López-Hoyos M, Brunet M, Muro M. High frequency of central memory regulatory T cells allows detection of liver recipients at risk of early acute rejection within the first month after transplantation. Int Immunol 2016;28:55-64. [PMID: 26270267 DOI: 10.1093/intimm/dxv048] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
44 Luxon BA. Diagnosis and treatment of autoimmune hepatitis. Gastroenterol Clin North Am 2008;37:461-78, vii-viii. [PMID: 18499031 DOI: 10.1016/j.gtc.2008.02.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
45 Liu Y, Qin X, Lei Z, Chai H, Wu Z. Diphenyleneiodonium ameliorates acute liver rejection during transplantation by inhibiting neutrophil extracellular traps formation in vivo. Transpl Immunol 2021;68:101434. [PMID: 34216758 DOI: 10.1016/j.trim.2021.101434] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
46 Shahid A, Punshi A, Ahmed Khan B, Nazir MB, Ullah H. Type 2 Autoimmune Hepatitis in a Male Patient with a Rare Complication of Vasculitis. Cureus 2020;12:e7354. [PMID: 32328366 DOI: 10.7759/cureus.7354] [Reference Citation Analysis]
47 Jadlowiec CC, Morgan PE, Nehra AK, Hathcock MA, Kremers WK, Heimbach JK, Wiesner RH, Taner T. Not All Cellular Rejections Are the Same: Differences in Early and Late Hepatic Allograft Rejection. Liver Transpl. 2019;25:425-435. [PMID: 30615251 DOI: 10.1002/lt.25411] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
48 Motegi A, Kinoshita M, Sato K, Shinomiya N, Ono S, Nonoyama S, Hiraide H, Seki S. An in vitro Shwartzman reaction-like response is augmented age-dependently in human peripheral blood mononuclear cells. J Leukoc Biol 2006;79:463-72. [PMID: 16387840 DOI: 10.1189/jlb.0705396] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
49 Dogan N, Hüsing-Kabar A, Schmidt HH, Cicinnati VR, Beckebaum S, Kabar I. Acute allograft rejection in liver transplant recipients: Incidence, risk factors, treatment success, and impact on graft failure. J Int Med Res 2018;46:3979-90. [PMID: 29996675 DOI: 10.1177/0300060518785543] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
50 Bitetto D, Fabris C, Falleti E, Fornasiere E, Avellini C, Cmet S, Cussigh A, Fontanini E, Pirisi M, Corradini SG, Merli M, Molinaro A, Toniutto P. Recipient interleukin-28B Rs12979860 C/T polymorphism and acute cellular rejection after liver transplantation: role of the calcineurin inhibitor used. Transplantation. 2012;93:1038-1044. [PMID: 22495472 DOI: 10.1097/tp.0b013e31824df7f3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
51 Rivero M, Crespo J, Mayorga M, Fábrega E, Casafont F, Pons-Romero F. Involvement of the Fas system in liver allograft rejection. Am J Gastroenterol. 2002;97:1501-1506. [PMID: 12094873 DOI: 10.1111/j.1572-0241.2002.05797.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
52 Duffy JP, Kao K, Ko CY, Farmer DG, McDiarmid SV, Hong JC, Venick RS, Feist S, Goldstein L, Saab S. Long-term patient outcome and quality of life after liver transplantation: analysis of 20-year survivors. Ann Surg. 2010;252:652-661. [PMID: 20881772 DOI: 10.1097/sla.0b013e3181f5f23a] [Cited by in Crossref: 49] [Cited by in F6Publishing: 51] [Article Influence: 4.1] [Reference Citation Analysis]
53 Liu LU, Bodian CA, Gondolesi GE, Schwartz ME, Emre S, Roayaie S, Schiano TD. Marked Differences in acute cellular rejection rates between living-donor and deceased-donor liver transplant recipients. Transplantation. 2005;80:1072-1080. [PMID: 16278588 DOI: 10.1097/01.tp.0000176483.52769.5a] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 1.8] [Reference Citation Analysis]
54 Rodrigues MG, Castro PMV, Almeida TC, Danziere FR, Sergi Filho FA, Zeballos Sempertegui BE, Branez JR, Mota LT, Perosa de Miranda M, Gomes Dos Santos R, Genzini T. Impact of Cold Ischemia Time on the Function of Liver Grafts Preserved With Custodiol. Transplant Proc 2021;53:661-4. [PMID: 33139037 DOI: 10.1016/j.transproceed.2020.03.002] [Reference Citation Analysis]
55 Ziolkowski J, Paczek L, Niewczas M, Senatorski G, Oldakowska-jedynak U, Wyzgal J, Foroncewicz B, Mucha K, Zegarska J, Nyckowski P, Zieniewicz K, Patkowski W, Krawczyk M, Ziarkiewicz-wroblewska B, Gornicka B. Effect of immunosuppressive regimen on acute rejection and liver graft function. Transplantation Proceedings 2003;35:2281-3. [DOI: 10.1016/s0041-1345(03)00794-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
56 Gómez-Manero N, Herrero JI, Quiroga J, Sangro B, Pardo F, Cienfuegos JA, Prieto J. Prognostic model for early acute rejection after liver transplantation. Liver Transpl. 2001;7:246-254. [PMID: 11244167 DOI: 10.1053/jlts.2001.22460] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 1.3] [Reference Citation Analysis]
57 Tapirdamaz O, Pravica V, Metselaar HJ, Hansen B, Moons L, van Meurs JB, Hutchinson IV, Shaw J, Agarwal K, Adams DH. Polymorphisms in the T cell regulatory gene cytotoxic T lymphocyte antigen 4 influence the rate of acute rejection after liver transplantation. Gut. 2006;55:863-868. [PMID: 16299026 DOI: 10.1136/gut.2005.080937] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.1] [Reference Citation Analysis]
58 Varotti G, Grazi GL, Vetrone G, Ercolani G, Cescon M, Del Gaudio M, Ravaioli M, Cavallari A, Pinna A. Causes of early acute graft failure after liver transplantation: analysis of a 17-year single-centre experience. Clin Transplant. 2005;19:492-500. [PMID: 16008594 DOI: 10.1111/j.1399-0012.2005.00373.x] [Cited by in Crossref: 66] [Cited by in F6Publishing: 57] [Article Influence: 3.9] [Reference Citation Analysis]
59 Rudow DL, Goldstein MJ. Critical care management of the liver transplant recipient. Crit Care Nurs Q 2008;31:232-43. [PMID: 18574371 DOI: 10.1097/01.CNQ.0000325048.01776.f2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
60 Wang YC, Wu TJ, Wu TH, Lee CF, Chou HS, Chan KM, Lee WC. The risk factors to predict acute rejection in liver transplantation. Transplant Proc. 2012;44:526-528. [PMID: 22410062 DOI: 10.1016/j.transproceed.2012.01.041] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
61 Ascha MS, Ascha ML, Hanouneh IA. Management of immunosuppressant agents following liver transplantation: Less is more. World J Hepatol 2016; 8(3): 148-161 [PMID: 26839639 DOI: 10.4254/wjh.v8.i3.148] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
62 Bolognesi M, Sacerdoti D, Mescoli C, Nava V, Bombonato G, Merkel C, Merenda R, Angeli P, Rugge M, Gatta A. Acute Liver Rejection: Accuracy and Predictive Values of Doppler US Measurements—Initial Experience. Radiology 2005;235:651-8. [DOI: 10.1148/radiol.2352040506] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
63 Jazrawi SF, Zaman A, Muhammad Z, Rabkin JM, Corless CL, Olyaei A, Biggs A, Ham J, Chou S, Rosen HR. Tumor necrosis factor-alpha promoter polymorphisms and the risk of rejection after liver transplantation: a case control analysis of 210 donor-recipient pairs. Liver Transpl. 2003;9:377-382. [PMID: 12682890 DOI: 10.1053/jlts.2003.50064] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 0.9] [Reference Citation Analysis]
64 Durand F. How to improve long-term outcome after liver transplantation? Liver Int. 2018;38 Suppl 1:134-138. [PMID: 29427483 DOI: 10.1111/liv.13651] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 9.0] [Reference Citation Analysis]
65 Wiesner RH, Rakela J, Ishitani MB, Mulligan DC, Spivey JR, Steers JL, Krom RA. Recent advances in liver transplantation. Mayo Clin Proc. 2003;78:197-210. [PMID: 12583530 DOI: 10.4065/78.2.197] [Cited by in Crossref: 69] [Cited by in F6Publishing: 48] [Article Influence: 3.6] [Reference Citation Analysis]
66 Shetty S, Adams DH, Hubscher SG. Post-transplant liver biopsy and the immune response: lessons for the clinician. Expert Review of Clinical Immunology 2014;8:645-61. [DOI: 10.1586/eci.12.65] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
67 Mcdiarmid S. Management of the pediatric liver transplant patient. Liver Transplantation 2001;7:S77-86. [DOI: 10.1053/jlts.2001.28643] [Cited by in Crossref: 32] [Cited by in F6Publishing: 23] [Article Influence: 1.5] [Reference Citation Analysis]
68 Boix F, Millan O, San Segundo D, Mancebo E, Rimola A, Fabrega E, Fortuna V, Mrowiec A, Castro-Panete MJ, Peña Jde L, Llorente S, Minguela A, Bolarin JM, Paz-Artal E, Lopez-Hoyos M, Brunet M, Muro M. High expression of CD38, CD69, CD95 and CD154 biomarkers in cultured peripheral T lymphocytes correlates with an increased risk of acute rejection in liver allograft recipients. Immunobiology 2016;221:595-603. [PMID: 26850323 DOI: 10.1016/j.imbio.2016.01.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
69 Shi XL, de Mare-Bredemeijer EL, Tapirdamaz Ö, Hansen BE, van Gent R, van Campenhout MJ, Mancham S, Litjens NH, Betjes MG, van der Eijk AA, Xia Q, van der Laan LJ, de Jonge J, Metselaar HJ, Kwekkeboom J. CMV Primary Infection Is Associated With Donor-Specific T Cell Hyporesponsiveness and Fewer Late Acute Rejections After Liver Transplantation. Am J Transplant 2015;15:2431-42. [PMID: 25943855 DOI: 10.1111/ajt.13288] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
70 Uesugi M, Masuda S, Katsura T, Oike F, Takada Y, Inui K. Effect of intestinal CYP3A5 on postoperative tacrolimus trough levels in living-donor liver transplant recipients. Pharmacogenetics and Genomics 2006;16:119-27. [DOI: 10.1097/01.fpc.0000184953.31324.e4] [Cited by in Crossref: 101] [Cited by in F6Publishing: 83] [Article Influence: 6.3] [Reference Citation Analysis]
71 Zhong C, Xi Z, Xia Q. Clinical analysis of liver transplantation in autoimmune liver diseases. Hepatobiliary & Pancreatic Diseases International 2018;17:27-31. [DOI: 10.1016/j.hbpd.2018.01.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
72 Bitetto D, Fabris C, Falleti E, Fornasiere E, Fumolo E, Fontanini E, Cussigh A, Occhino G, Baccarani U, Pirisi M. Vitamin D and the risk of acute allograft rejection following human liver transplantation. Liver Int. 2010;30:417-444. [PMID: 19849776 DOI: 10.1111/j.1478-3231.2009.02154.x] [Cited by in Crossref: 59] [Cited by in F6Publishing: 46] [Article Influence: 4.5] [Reference Citation Analysis]
73 Wiesner RH, Fung JJ. Present state of immunosuppressive therapy in liver transplant recipients. Liver Transpl. 2011;17 Suppl 3:S1-S9. [PMID: 21850697 DOI: 10.1002/lt.22410] [Cited by in Crossref: 71] [Cited by in F6Publishing: 60] [Article Influence: 7.1] [Reference Citation Analysis]
74 Haugaa H, Thorgersen EB, Pharo A, Boberg KM, Foss A, Line PD, Sanengen T, Almaas R, Grindheim G, Pischke SE, Mollnes TE, Tønnessen TI. Early bedside detection of ischemia and rejection in liver transplants by microdialysis: Microdialysis in Liver Graft Rejection and Ischemia. Liver Transpl 2012;18:839-49. [DOI: 10.1002/lt.23425] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 3.3] [Reference Citation Analysis]
75 Jin H, Dahmen U, Liu A, Huang H, Gu Y, Dirsch O. Prolonged Cold Ischemia Does Not Trigger Lethal Rejection or Accelerate the Acute Rejection in Two Allogeneic Rat Liver Transplantation Models. Journal of Surgical Research 2012;175:322-32. [DOI: 10.1016/j.jss.2011.03.078] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
76 Lee SJ, Kim KW, Kim JH, Kim SY, Lee JS, Kim HJ, Jung D, Song G, Hwang S, Yu ES, Lee J, Lee S. Doppler Sonography of Patients With and Without Acute Cellular Rejection After Right-Lobe Living Donor Liver Transplantation. Journal of Ultrasound in Medicine 2012;31:845-51. [DOI: 10.7863/jum.2012.31.6.845] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
77 Kubal CA, Mangus RS, Saxena R, Lobashevsky A, Higgins N, Agarwal A, Fridell JA, Tector AJ. Crossmatch-positive liver transplantation in patients receiving thymoglobulin-rituximab induction. Transplantation 2014;97:56-63. [PMID: 24030603 DOI: 10.1097/TP.0b013e3182a688c0] [Cited by in Crossref: 18] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
78 Shafiei M, Alavian SM. Autoimmune hepatitis in Iran: what we know, what we don't know and requirements for better management. Hepat Mon 2012;12:73-6. [PMID: 22509182 DOI: 10.5812/hepatmon.840] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
79 van Gent R, Metselaar HJ, Kwekkeboom J. Immunomodulation by hyperimmunoglobulins after solid organ transplantation: Beyond prevention of viral infection. Transplant Rev (Orlando) 2017;31:78-86. [PMID: 28131494 DOI: 10.1016/j.trre.2017.01.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
80 Kueht ML, Cotton RT, Galvan NT, O'Mahony CA, Goss JA, Rana A. Profiling immunologic risk for acute rejection in liver transplantation: Recipient age is an important risk factor. Transpl Immunol 2016;38:44-9. [PMID: 27423762 DOI: 10.1016/j.trim.2016.07.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
81 Nashan B, Cole E, Levy G, Thervet E. Clinical validation studies of neoral C2 monitoring: a review: . Transplantation 2002;73:S3-S11. [DOI: 10.1097/00007890-200205151-00002] [Cited by in Crossref: 93] [Cited by in F6Publishing: 80] [Article Influence: 4.7] [Reference Citation Analysis]
82 Krasinskas AM, Demetris AJ, Poterucha JJ, Abraham SC. The prevalence and natural history of untreated isolated central perivenulitis in adult allograft livers. Liver Transpl 2008;14:625-32. [DOI: 10.1002/lt.21404] [Cited by in Crossref: 47] [Cited by in F6Publishing: 31] [Article Influence: 3.4] [Reference Citation Analysis]
83 Lee CF, Wang YC, Cheng CH, Wu TH, Chen YC, Soong RS, Wu TJ, Chou HS, Chan KM, Lee WC. Application of CD8+ Cells Count as a Guide of Immunosuppressive Regimen Introduction for Very Sick Patients Undergoing Liver Transplantation. Transplant Proc 2016;48:3356-61. [PMID: 27931581 DOI: 10.1016/j.transproceed.2016.09.038] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
84 Demetris AJ, Lunz JG 3rd, Randhawa P, Wu T, Nalesnik M, Thomson AW. Monitoring of human liver and kidney allograft tolerance: a tissue/histopathology perspective. Transpl Int 2009;22:120-41. [PMID: 18980624 DOI: 10.1111/j.1432-2277.2008.00765.x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 40] [Article Influence: 3.4] [Reference Citation Analysis]
85 St A Nunes FA, Lucey MR. Searching for a balance when applying immunosuppression after liver transplantation. Transplantation 2001;71:495-6. [PMID: 11258425 DOI: 10.1097/00007890-200102270-00001] [Reference Citation Analysis]
86 Marubashi S, Dono K, Nagano H, Asaoka T, Hama N, Kobayashi S, Miyamoto A, Takeda Y, Umeshita K, Monden M. Postoperative hyperbilirubinemia and graft outcome in living donor liver transplantation. Liver Transpl. 2007;13:1538-1544. [PMID: 17969209 DOI: 10.1002/lt.21345] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
87 Demetris AJ, Eghtesad B, Marcos A, Ruppert K, Nalesnik MA, Randhawa P, Wu T, Krasinskas A, Fontes P, Cacciarelli T, Shakil AO, Murase N, Fung JJ, Starzl TE. Recurrent Hepatitis C in Liver Allografts: Prospective Assessment of Diagnostic Accuracy, Identification of Pitfalls, and Observations About Pathogenesis. The American Journal of Surgical Pathology 2004;28:658-69. [DOI: 10.1097/00000478-200405000-00015] [Cited by in Crossref: 80] [Cited by in F6Publishing: 55] [Article Influence: 4.4] [Reference Citation Analysis]
88 Pascher A, Nebrig M, Neuhaus P. Irreversible liver failure: treatment by transplantation: part 3 of a series on liver cirrhosis. Dtsch Arztebl Int 2013;110:167-73. [PMID: 23533548 DOI: 10.3238/arztebl.2013.0167] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
89 Andreu H, Rimola A, Bruguera M, Navasa M, Cirera I, Grande L, Garcia-valdecasas J, Rodes J. Acute cellular rejection in liver transplant recipients under cyclosporine immunosuppression: predictive factors of response to antirejection therapy: . Transplantation 2002;73:1936-43. [DOI: 10.1097/00007890-200206270-00016] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
90 Goddard S, Adams DH. New approaches to immunosuppression in liver transplantation. Journal of Gastroenterology and Hepatology 2002;17:116-26. [DOI: 10.1046/j.1440-1746.2002.02633.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
91 Sudan DL, Kaufman SS, Shaw BW Jr, Fox IJ, McCashland TM, Schafer DF, Radio SJ, Hinrichs SH, Vanderhoof JA, Langnas AN. Isolated intestinal transplantation for intestinal failure. Am J Gastroenterol. 2000;95:1506-1515. [PMID: 10894588 DOI: 10.1111/j.1572-0241.2000.02088.x] [Cited by in Crossref: 143] [Cited by in F6Publishing: 112] [Article Influence: 6.5] [Reference Citation Analysis]
92 Dʼantiga L, Dhawan A, Portmann B, Francavilla R, Rela M, Heaton N, Mieli-vergani G. LATE CELLULAR REJECTION IN PAEDIATRIC LIVER TRANSPLANTATION: AETIOLOGY AND OUTCOME. Transplantation 2002;73:80-4. [DOI: 10.1097/00007890-200201150-00015] [Cited by in Crossref: 60] [Cited by in F6Publishing: 44] [Article Influence: 3.0] [Reference Citation Analysis]
93 San Segundo D, Ruiz P, Irure J, Arias-Loste MT, Cuadrado A, Puente A, Casafont F, López-Hoyos M, Crespo J, Fábrega E. Serum Levels of Interleukin-34 During Acute Rejection in Liver Transplantation. Transplant Proc 2016;48:2977-9. [PMID: 27932123 DOI: 10.1016/j.transproceed.2016.08.038] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
94 Demetris AJ. Evolution of hepatitis C virus in liver allografts. Liver Transpl. 2009;15 Suppl 2:S35-S41. [PMID: 19876940 DOI: 10.1002/lt.21890] [Cited by in Crossref: 59] [Cited by in F6Publishing: 43] [Article Influence: 4.9] [Reference Citation Analysis]
95 Shizuku M, Kamei H, Yoshizawa A, Ito Y, Ogura Y, Yoshikawa J, Kurata N, Jobara K, Kodera Y. The impact of chronic Epstein-Barr virus infection on the liver graft of pediatric liver transplant recipients: A retrospective observational study. Transpl Infect Dis 2021;23:e13731. [PMID: 34500501 DOI: 10.1111/tid.13731] [Reference Citation Analysis]
96 Rodríguez-Perálvarez M, Germani G, Darius T, Lerut J, Tsochatzis E, Burroughs AK. Tacrolimus trough levels, rejection and renal impairment in liver transplantation: a systematic review and meta-analysis. Am J Transplant. 2012;12:2797-2814. [PMID: 22703529 DOI: 10.1111/j.1600-6143.2012.04140.x] [Cited by in Crossref: 97] [Cited by in F6Publishing: 86] [Article Influence: 10.8] [Reference Citation Analysis]
97 Volpin R, Angeli P, Galioto A, Fasolato S, Neri D, Barbazza F, Merenda R, Del Piccolo F, Strazzabosco M, Casagrande F. Comparison between two high-dose methylprednisolone schedules in the treatment of acute hepatic cellular rejection in liver transplant recipients: a controlled clinical trial. Liver Transpl. 2002;8:527-534. [PMID: 12037783 DOI: 10.1053/jlts.2002.33456] [Cited by in Crossref: 35] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
98 Charlton MR. How important is acute cellular rejection?: How Important is Acute Cellular Rejection? Liver Transpl 2013;19:S9-S13. [DOI: 10.1002/lt.23743] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
99 Ben-Ari Z, Czaja AJ. Autoimmune hepatitis and its variant syndromes. Gut 2001;49:589-94. [PMID: 11559660 DOI: 10.1136/gut.49.4.589] [Cited by in Crossref: 69] [Cited by in F6Publishing: 53] [Article Influence: 3.3] [Reference Citation Analysis]
100 Kim YK, Kim SH, Moon IS, Han SS, Cho SY, You T, Park SJ. The effect of a positive T-lymphocytotoxic crossmatch on clinical outcomes in adult-to-adult living donor liver transplantation. J Korean Surg Soc 2013;84:245-51. [PMID: 23577320 DOI: 10.4174/jkss.2013.84.4.245] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
101 Jang JK, Kim KW, Choi SH, Jeong SY, Kim JH, Yu ES, Kwon JH, Song GW, Lee SG. CT of acute rejection after liver transplantation: a matched case-control study. Eur Radiol 2019;29:3736-45. [PMID: 30707276 DOI: 10.1007/s00330-018-5971-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
102 Wiesner RH, Menon KV. Late hepatic allograft dysfunction. Liver Transpl. 2001;7:S60-S73. [PMID: 11689778 DOI: 10.1053/jlts.2001.29094] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 1.4] [Reference Citation Analysis]
103 McCaughan GW, Omata M, Amarapurkar D, Bowden S, Chow WC, Chutaputti A, Dore G, Gane E, Guan R, Hamid SS. Asian Pacific Association for the Study of the Liver consensus statements on the diagnosis, management and treatment of hepatitis C virus infection. J Gastroenterol Hepatol. 2007;22:615-633. [PMID: 17444847 DOI: 10.1111/j.1440-1746.2007.04883.x] [Cited by in Crossref: 111] [Cited by in F6Publishing: 111] [Article Influence: 7.4] [Reference Citation Analysis]
104 Lake J. Benefits of cyclosporine microemulsion (Neoral) C2 monitoring are sustained at 1 year in de novo liver transplant recipients. Transplantation Proceedings 2001;33:3092-3. [DOI: 10.1016/s0041-1345(01)02317-x] [Cited by in Crossref: 17] [Article Influence: 0.8] [Reference Citation Analysis]
105 Moreira RK. Recurrent hepatitis C and acute allograft rejection: clinicopathologic features with emphasis on the differential diagnosis between these entities. Adv Anat Pathol. 2011;18:393-405. [PMID: 21841407 DOI: 10.1097/pap.0b013e31822a5a10] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 0.9] [Reference Citation Analysis]
106 Liu LU, Schiano TD, Lau N, O'rourke M, Min AD, Sigal SH, Drooker M, Bodenheimer HC. Survival and Risk of Recidivism in Methadone‐Dependent Patients Undergoing Liver Transplantation. American Journal of Transplantation 2003;3:1273-7. [DOI: 10.1046/j.1600-6143.2003.00199.x] [Cited by in Crossref: 47] [Cited by in F6Publishing: 35] [Article Influence: 2.5] [Reference Citation Analysis]
107 Kremers WK, Devarbhavi HC, Wiesner RH, Krom RA, Macon WR, Habermann TM. Post-transplant lymphoproliferative disorders following liver transplantation: Incidence, risk factors and survival. Am J Transplant. 2006;6:1017-1024. [PMID: 16611339 DOI: 10.1111/j.1600-6143.2006.01294.x] [Cited by in Crossref: 110] [Cited by in F6Publishing: 79] [Article Influence: 6.9] [Reference Citation Analysis]
108 Dufour DR. Liver Disease. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics. Elsevier; 2012. pp. 1637-93. [DOI: 10.1016/b978-1-4160-6164-9.00050-0] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
109 de la Peña-moral JM, Pons JA, Tome S, Gude F, Miras M, Bermejo J, Ramirez P, Berenguer M, Varo E, Forteza J, Parrilla P. Acute cellular rejection versus recurrent hepatitis C after liver transplantation: Clinical and pathological features driving a rational diagnostic approach: Acute rejection vs recurrent HCV after LT. Hepatol Res 2015;45:423-31. [DOI: 10.1111/hepr.12369] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
110 Henson JB, Patel YA, Wilder JM, Zheng J, Chow SC, King LY, Muir AJ. Differences in Phenotypes and Liver Transplantation Outcomes by Age Group in Patients with Primary Sclerosing Cholangitis. Dig Dis Sci 2017;62:3200-9. [PMID: 28391417 DOI: 10.1007/s10620-017-4559-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
111 Figueiredo F, Dickson ER, Pasha T, Kasparova P, Therneau T, Malinchoc M, DiCecco S, Francisco-Ziller N, Charlton M. Impact of nutritional status on outcomes after liver transplantation. Transplantation. 2000;70:1347-1352. [PMID: 11087151 DOI: 10.1097/00007890-200011150-00014] [Cited by in Crossref: 114] [Cited by in F6Publishing: 96] [Article Influence: 5.2] [Reference Citation Analysis]
112 Freitas ACT, Matos DMN, Milsted JAT, Coelho JCU. EFFECTS OF COLD ISCHEMIA TIME ON HEPATIC ALLOGRAFT FUNCTION. Arq Bras Cir Dig 2017;30:239-43. [PMID: 29340545 DOI: 10.1590/0102-6720201700040003] [Cited by in Crossref: 4] [Article Influence: 1.0] [Reference Citation Analysis]
113 Northup PG, Abecassis MM, Englesbe MJ, Emond JC, Lee VD, Stukenborg GJ, Tong L, Berg CL; Adult-to-Adult Living Donor Liver Transplantation Cohort Study Group. Addition of adult-to-adult living donation to liver transplant programs improves survival but at an increased cost. Liver Transpl 2009;15:148-62. [PMID: 19177435 DOI: 10.1002/lt.21671] [Cited by in Crossref: 34] [Cited by in F6Publishing: 25] [Article Influence: 2.6] [Reference Citation Analysis]
114 Bathgate AJ, Lee P, Hayes PC, Simpson KJ. Pretransplantation tumor necrosis factor-alpha production predicts acute rejection after liver transplantation. Liver Transpl. 2000;6:721-727. [PMID: 11084058 DOI: 10.1053/jlts.2000.18472] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 0.9] [Reference Citation Analysis]
115 González MG, Madrazo CP, Rodríguez AB, Gutiérrez MG, Herrero JI, Pallardó JM, Ortiz de Urbina J, Paricio PP. An open, randomized, multicenter clinical trial of oral tacrolimus in liver allograft transplantation: a comparison of dual vs. triple drug therapy. Liver Transpl 2005;11:515-24. [PMID: 15838889 DOI: 10.1002/lt.20382] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
116 Gane EJ. The natural history of recurrent hepatitis C and what influences this. Liver Transpl. 2008;14 Suppl 2:S36-S44. [PMID: 18825724 DOI: 10.1002/lt.21646] [Cited by in Crossref: 203] [Cited by in F6Publishing: 172] [Article Influence: 15.6] [Reference Citation Analysis]
117 Bathgate AJ, Hynd P, Sommerville D, Hayes PC. The prediction of acute cellular rejection in orthotopic liver transplantation. Liver Transpl Surg 1999;5:475-9. [PMID: 10545533 DOI: 10.1002/lt.500050608] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 1.6] [Reference Citation Analysis]
118 Olson JC, Wiesner RH. Immunomodulating therapy in liver transplantation: principles and practice. Immunotherapy 2012;4:793-805. [PMID: 22947008 DOI: 10.2217/imt.12.69] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
119 Tang Y, Zhao J, Yu H, Wu H, Niu N. Acoustic Radiation Force Impulse and Doppler Ultrasonography: Comprehensive Evaluation of Acute Rejection After Liver Transplantation. J Ultrasound Med 2017;36:1137-45. [PMID: 28244127 DOI: 10.7863/ultra.16.05052] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
120 Luxon BA. Autoimmune hepatitis: diagnosis, treatment, and prognosis. Curr Gastroenterol Rep 2006;8:83-8. [PMID: 16510039 DOI: 10.1007/s11894-006-0068-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
121 Trotter JF. Sirolimus in liver transplantation. Transplant Proc. 2003;35:193S-200S. [PMID: 12742496 DOI: 10.1016/S0041-1345(03)00234-3] [Cited by in Crossref: 91] [Cited by in F6Publishing: 17] [Article Influence: 4.8] [Reference Citation Analysis]
122 Kovandova B, Slavcev A, Honsova E, Erhartova D, Skibova J, Viklicky O, Trunecka P. De novo HLA Class II antibodies are associated with the development of chronic but not acute antibody-mediated rejection after liver transplantation - a retrospective study. Transpl Int 2020;33:1799-806. [PMID: 33020979 DOI: 10.1111/tri.13763] [Reference Citation Analysis]
123 González-Koch A, Czaja AJ, Carpenter HA, Roberts SK, Charlton MR, Porayko MK, Rosen CB, Wiesner RH. Recurrent autoimmune hepatitis after orthotopic liver transplantation. Liver Transpl. 2001;7:302-310. [PMID: 11303289 DOI: 10.1053/jlts.2001.21449] [Cited by in Crossref: 142] [Cited by in F6Publishing: 109] [Article Influence: 6.8] [Reference Citation Analysis]
124 Samonakis DN, Mela M, Quaglia A, Triantos CK, Thalheimer U, Leandro G, Pesci A, Raimondo ML, Dhillon AP, Rolles K. Rejection rates in a randomised trial of tacrolimus monotherapy versus triple therapy in liver transplant recipients with hepatitis C virus cirrhosis. Transpl Infect Dis. 2006;8:3-12. [PMID: 16623815 DOI: 10.1111/j.1399-3062.2006.00124.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 1.9] [Reference Citation Analysis]
125 Turka LA, Wood K, Bluestone JA. Bringing transplantation tolerance into the clinic: lessons from the ITN and RISET for the Establishment of Tolerance consortia. Curr Opin Organ Transplant 2010;15:441-8. [PMID: 20631613 DOI: 10.1097/MOT.0b013e32833bd371] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
126 Zandieh I, Krygier D, Wong V, Howard J, Worobetz L, Minuk G, Witt-Sullivan H, Yoshida EM. The use of budesonide in the treatment of autoimmune hepatitis in Canada. Can J Gastroenterol 2008;22:388-92. [PMID: 18414714 DOI: 10.1155/2008/509459] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 2.0] [Reference Citation Analysis]
127 Sugawara Y, Makuuchi M, Kaneko J, Saiura A, Imamura H, Kokudo N. Risk factors for acute rejection in living donor liver transplantation: HLA matching in LDLT. Clinical Transplantation 2003;17:347-52. [DOI: 10.1034/j.1399-0012.2003.00057.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 1.2] [Reference Citation Analysis]
128 Al-Khalidi JA, Czaja AJ. Current concepts in the diagnosis, pathogenesis, and treatment of autoimmune hepatitis. Mayo Clin Proc. 2001;76:1237-1252. [PMID: 11761505 DOI: 10.4065/76.12.1237] [Cited by in Crossref: 30] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
129 Durand F, Belghiti J. Transplantation hépatique chez l’adulte. Med Sci (Paris) 2005;21:89-94. [DOI: 10.1051/medsci/200521189] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
130 Harper SJ, Gelson W, Harper IG, Alexander GJ, Gibbs P. Switching to sirolimus-based immune suppression after liver transplantation is safe and effective: a single-center experience. Transplantation 2011;91:128-32. [PMID: 21452417 DOI: 10.1097/tp.0b013e3181fe131b] [Cited by in Crossref: 30] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
131 Czaja AJ, Freese DK; American Association for the Study of Liver Disease. Diagnosis and treatment of autoimmune hepatitis. Hepatology. 2002;36:479-497. [PMID: 12143059 DOI: 10.1053/jhep.2002.34944] [Cited by in Crossref: 404] [Cited by in F6Publishing: 355] [Article Influence: 20.2] [Reference Citation Analysis]
132 Krok KL, Thuluvath PJ. Perioperative and postoperative use of immunosuppressive agents in liver transplantation. Int Anesthesiol Clin 2006;44:51-68. [PMID: 16832206 DOI: 10.1097/01.aia.0000210803.45383.35] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
133 Petite SE, Bollinger JE, Eghtesad B. Antithymocyte Globulin Induction Therapy in Liver Transplant: Old Drug, New Uses. Ann Pharmacother 2016;50:592-8. [PMID: 27147705 DOI: 10.1177/1060028016647974] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
134 McDiarmid SV. Current status of liver transplantation in children. Pediatr Clin North Am. 2003;50:1335-1374. [PMID: 14710783 DOI: 10.1016/S0031-3955(03)00150-0] [Cited by in Crossref: 62] [Cited by in F6Publishing: 7] [Article Influence: 3.4] [Reference Citation Analysis]
135 Lee B, Choi Y, Cho JY, Yoon YS, Han HS. Neutrophil-to-lymphocyte ratio predicts early acute cellular rejection in living donor liver transplantation. Ann Surg Treat Res 2020;99:337-43. [PMID: 33304861 DOI: 10.4174/astr.2020.99.6.337] [Reference Citation Analysis]
136 Abdollahi MR, Somi MH, Faraji E. Role of international criteria in the diagnosis of autoimmune hepatitis. World J Gastroenterol 2013; 19(23): 3629-3633 [PMID: 23801865 DOI: 10.3748/wjg.v19.i23.3629] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
137 Ho CM, Chen HL, Hu RH, Lee PH. Harnessing immunotherapy for liver recipients with hepatocellular carcinoma: a review from a transplant oncology perspective. Ther Adv Med Oncol 2019;11:1758835919843463. [PMID: 31065295 DOI: 10.1177/1758835919843463] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
138 O’Riordan A, Wong V, McQuillan R, McCormick PA, Hegarty JE, Watson AJ. Acute renal disease, as defined by the RIFLE criteria, post-liver transplantation. Am J Transplant. 2007;7:168-176. [PMID: 17109735 DOI: 10.1111/j.1600-6143.2006.01602.x] [Cited by in Crossref: 137] [Cited by in F6Publishing: 112] [Article Influence: 8.6] [Reference Citation Analysis]
139 Mazariegos GV, Salzedas AA, Zavatsky J, Sindhi R, Parizhskaya M, McGhee W, Jain A, Reyes J. Long term management of liver transplant rejection in children. BioDrugs 2000;14:31-48. [PMID: 18034554 DOI: 10.2165/00063030-200014010-00004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
140 Gawrieh S, Papouchado BG, Burgart LJ, Kobayashi S, Charlton MR, Gores GJ. Early hepatic stellate cell activation predicts severe hepatitis C recurrence after liver transplantation. Liver Transpl 2005;11:1207-13. [DOI: 10.1002/lt.20455] [Cited by in Crossref: 51] [Cited by in F6Publishing: 47] [Article Influence: 3.0] [Reference Citation Analysis]
141 Demetris A, Crawford JM, Minervini MI, Nalesnik M, Ochoa E, Randhawa P, Sasatomi E, Wu T. Transplantation Pathology of the Liver. Surgical Pathology of the GI Tract, Liver, Biliary Tract, and Pancreas. Elsevier; 2009. pp. 1169-229. [DOI: 10.1016/b978-141604059-0.50047-3] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
142 Marder BA, Schröppel B, Lin M, Schiano T, Parekh R, Tomer Y, Murphy B. The impact of costimulatory molecule gene polymorphisms on clinical outcomes in liver transplantation. Am J Transplant 2003;3:424-31. [PMID: 12694064 DOI: 10.1034/j.1600-6143.2003.00084.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 1.6] [Reference Citation Analysis]
143 Florman S, Alloway R, Kalayoglu M, Punch J, Bak T, Melancon J, Klintmalm G, Busque S, Charlton M, Lake J, Dhadda S, Wisemandle K, Wirth M, Fitzsimmons W, Holman J, First MR. Once-Daily Tacrolimus Extended Release Formulation: Experience at 2 Years Postconversion From a Prograf-Based Regimen in Stable Liver Transplant Recipients. Transplantation 2007;83:1639-42. [DOI: 10.1097/01.tp.0000265445.09987.f1] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 2.5] [Reference Citation Analysis]
144 Wang WL, Yao MY, Jin J, Jia CK, Gao LH, Xie HY, Zheng SS. Increased expression of non-interleukin-2 T cell growth factors and their implications during liver allograft rejection in rats. J Gastroenterol Hepatol 2007;22:1141-7. [PMID: 17532783 DOI: 10.1111/j.1440-1746.2007.04925.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
145 Mukherjee S, Sorrell MF. Controversies in liver transplantation for hepatitis C. Gastroenterology. 2008;134:1777-1788. [PMID: 18471554 DOI: 10.1053/j.gastro.2008.02.035] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
146 Lerut JP, Gondolesi GE. Immunosuppression in liver and intestinal transplantation. Best Pract Res Clin Gastroenterol 2021;54-55:101767. [PMID: 34874848 DOI: 10.1016/j.bpg.2021.101767] [Reference Citation Analysis]
147 He J, Pu CJ, Wang M, Li ZH, Feng T, Zhao DK, Liu JK. Conosiligins A-D, Ring-Rearranged Tremulane Sesquiterpenoids from Conocybe siliginea. J Nat Prod 2020;83:2743-8. [PMID: 32816486 DOI: 10.1021/acs.jnatprod.0c00681] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
148 Demetris AJ, Ruppert K, Dvorchik I, Jain A, Minervini M, Nalesnik MA, Randhawa P, Wu T, Zeevi A, Abu-elmagd K, Eghtesad B, Fontes P, Cacciarelli T, Marsh W, Geller D, Fung JJ. Real-time monitoring of acute liver-allograft rejection using the Banff schema1: . Transplantation 2002;74:1290-6. [DOI: 10.1097/00007890-200211150-00016] [Cited by in Crossref: 74] [Cited by in F6Publishing: 52] [Article Influence: 3.7] [Reference Citation Analysis]
149 Breidenbach WC, Meister EA, Becker GW, Turker T, Gorantla VS, Hassan K, Kaplan B. A Statistical Comparative Assessment of Face and Hand Transplantation Outcomes to Determine Whether Either Meets the Standard of Care Threshold: . Plastic and Reconstructive Surgery 2016;137:214e-22e. [DOI: 10.1097/prs.0000000000001893] [Cited by in Crossref: 29] [Cited by in F6Publishing: 7] [Article Influence: 4.8] [Reference Citation Analysis]
150 Charlton MR. Improving Long-Term Outcomes After Liver Transplantation. Clinics in Liver Disease 2014;18:717-30. [DOI: 10.1016/j.cld.2014.05.011] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
151 Freedman BJ, Lowe SC, Saouaf R. MR IMAGING IN HEPATIC TRANSPLANTATION. Magnetic Resonance Imaging Clinics of North America 2001;9:821-39. [DOI: 10.1016/s1064-9689(21)00276-2] [Cited by in Crossref: 5] [Article Influence: 0.2] [Reference Citation Analysis]
152 Lucey MR. Serial liver biopsies: a gateway into understanding the long-term health of the liver allograft. J Hepatol. 2001;34:762-763. [PMID: 11434625 DOI: 10.1016/s0168-8278(01)00070-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
153 Kulkarni AV, Sarin SK, Choudhury A, Shashthry SM, Kumar K, Anand L. Role of microRNA in acute cellular rejection. Hepatology 2017;65:1423-4. [PMID: 28103634 DOI: 10.1002/hep.29063] [Reference Citation Analysis]
154 Rodrigo E, López-Hoyos M, Corral M, Fábrega E, Fernández-Fresnedo G, San Segundo D, Piñera C, Arias M. ImmuKnow as a diagnostic tool for predicting infection and acute rejection in adult liver transplant recipients: a systematic review and meta-analysis. Liver Transpl 2012;18:1245-53. [PMID: 22740321 DOI: 10.1002/lt.23497] [Cited by in Crossref: 57] [Cited by in F6Publishing: 55] [Article Influence: 6.3] [Reference Citation Analysis]
155 Rodríguez-Perálvarez M, Germani G, Papastergiou V, Tsochatzis E, Thalassinos E, Luong TV, Rolando N, Dhillon AP, Patch D, O’Beirne J. Early tacrolimus exposure after liver transplantation: relationship with moderate/severe acute rejection and long-term outcome. J Hepatol. 2013;58:262-270. [PMID: 23023010 DOI: 10.1016/j.jhep.2012.09.019] [Cited by in Crossref: 64] [Cited by in F6Publishing: 56] [Article Influence: 6.4] [Reference Citation Analysis]
156 Serrano J, Garcı́a González M, Gómez M, Ortiz de Urbina J, López Cillero P, San Juan F, Parrilla P, Herrero J. Tacrolimus is effective in both dual and triple regimens after liver transplantation. Transplantation Proceedings 2002;34:1529-30. [DOI: 10.1016/s0041-1345(02)03006-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
157 Trull A. Influence of albumin supplementation on tacrolimus and cyclosporine therapy early after liver transplantation. Liver Transplantation 2002;8:224-32. [DOI: 10.1053/jlts.2002.31347] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
158 Montano-Loza AJ, Bhanji RA, Wasilenko S, Mason AL. Systematic review: recurrent autoimmune liver diseases after liver transplantation. Aliment Pharmacol Ther. 2017;45:485-500. [PMID: 27957759 DOI: 10.1111/apt.13894] [Cited by in Crossref: 57] [Cited by in F6Publishing: 39] [Article Influence: 9.5] [Reference Citation Analysis]
159 Florman S, Schiano T, Kim L, Maman D, Levay A, Gondolesi G, Fishbein T, Emre S, Schwartz M, Miller C. The incidence and significance of late acute cellular rejection (> 1000 days) after liver transplantation. Clin Transplant. 2004;18:152-155. [PMID: 15016129 DOI: 10.1046/j.1399-0012.2003.00139.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
160 Kwekkeboom J, Tha-In T, Tra WM, Hop W, Boor PP, Mancham S, Zondervan PE, Vossen AC, Kusters JG, de Man RA. Hepatitis B immunoglobulins inhibit dendritic cells and T cells and protect against acute rejection after liver transplantation. Am J Transplant. 2005;5:2393-2402. [PMID: 16162187 DOI: 10.1111/j.1600-6143.2005.01029.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 2.2] [Reference Citation Analysis]
161 Carbone M, Neuberger JM. Autoimmune liver disease, autoimmunity and liver transplantation. J Hepatol. 2014;60:210-223. [PMID: 24084655 DOI: 10.1016/j.jhep.2013.09.020] [Cited by in Crossref: 119] [Cited by in F6Publishing: 93] [Article Influence: 13.2] [Reference Citation Analysis]
162 Guerra S, Mamede AC, Carvalho MJ, Laranjo M, Tralhão JG, Abrantes AM, Maia CJ, Botelho MF. Liver diseases: what is known so far about the therapy with human amniotic membrane? Cell Tissue Bank 2016;17:653-63. [PMID: 27550013 DOI: 10.1007/s10561-016-9579-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
163 Charlton M, Levitsky J, Aqel B, OʼGrady J, Hemibach J, Rinella M, Fung J, Ghabril M, Thomason R, Burra P, Little EC, Berenguer M, Shaked A, Trotter J, Roberts J, Rodriguez-Davalos M, Rela M, Pomfret E, Heyrend C, Gallegos-Orozco J, Saliba F. International Liver Transplantation Society Consensus Statement on Immunosuppression in Liver Transplant Recipients. Transplantation 2018;102:727-43. [PMID: 29485508 DOI: 10.1097/TP.0000000000002147] [Cited by in Crossref: 61] [Cited by in F6Publishing: 22] [Article Influence: 20.3] [Reference Citation Analysis]
164 Gaynor JJ, Moon JI, Kato T, Nishida S, Selvaggi G, Levi DM, Island ER, Pyrsopoulos N, Weppler D, Ganz S. A cause-specific hazard rate analysis of prognostic factors among 877 adults who received primary orthotopic liver transplantation. Transplantation. 2007;84:155-165. [PMID: 17667806 DOI: 10.1097/01.tp.0000269090.90068.0f] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
165 Herrero JI, Pardo F, D'avola D, Alegre F, Rotellar F, Iñarrairaegui M, Martí P, Sangro B, Quiroga J. Risk factors of lung, head and neck, esophageal, and kidney and urinary tract carcinomas after liver transplantation: The effect of smoking withdrawal: Malignancy After Smoking Withdrawal in LT. Liver Transpl 2011;17:402-8. [DOI: 10.1002/lt.22247] [Cited by in Crossref: 63] [Cited by in F6Publishing: 52] [Article Influence: 5.7] [Reference Citation Analysis]
166 Liu F, Li B, Wei Y, Ma Y, Yan L, Wen T. Tumor necrosis factor-alpha-308 G/A polymorphism and acute liver graft rejection: A meta-analysis. Transplant Immunology 2010;24:45-9. [DOI: 10.1016/j.trim.2010.09.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
167 Han ES, Na GH, Choi HJ, You YK, Kim DG. Effectiveness of Perioperative Immunologic Markers Monitoring for Predicting Early Acute Cellular Rejection After Living Donor Liver Transplantation. Transplant Proc 2019;51:2648-54. [PMID: 31477418 DOI: 10.1016/j.transproceed.2019.03.077] [Reference Citation Analysis]
168 Rodríguez-Perálvarez M, De la Mata M, Burroughs AK. Liver transplantation: immunosuppression and oncology. Curr Opin Organ Transplant. 2014;19:253-260. [PMID: 24685671 DOI: 10.1097/mot.0000000000000069] [Cited by in Crossref: 56] [Cited by in F6Publishing: 25] [Article Influence: 7.0] [Reference Citation Analysis]
169 Burton JR, Rosen HR. Acute rejection in HCV-infected liver transplant recipients: The great conundrum. Liver Transpl 2006;12:S38-47. [DOI: 10.1002/lt.20944] [Cited by in Crossref: 49] [Cited by in F6Publishing: 31] [Article Influence: 3.1] [Reference Citation Analysis]
170 Neuhaus P. Analysis of Risk Factors for the Development of Late Hepatic Artery Thrombosis: Do CREG Mismatches Play a Role? Liver Transplantation 2000;6:512-4. [DOI: 10.1053/jlts.2000.7574] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
171 Tippner C, Nashan B, Hoshino K, Schmidt-sandte E, Akimaru K, B??ker KH, Schlitt HJ. CLINICAL AND SUBCLINICAL ACUTE REJECTION EARLY AFTER LIVER TRANSPLANTATION: CONTRIBUTING FACTORS AND RELEVANCE FOR THE LONG-TERM COURSE. Transplantation 2001;72:1122-8. [DOI: 10.1097/00007890-200109270-00024] [Cited by in Crossref: 53] [Cited by in F6Publishing: 46] [Article Influence: 2.5] [Reference Citation Analysis]
172 Hübscher SG. Recurrent autoimmune hepatitis after liver transplantation: diagnostic criteria, risk factors, and outcome. Liver Transpl 2001;7:285-91. [PMID: 11303286 DOI: 10.1053/jlts.2001.23085] [Cited by in Crossref: 84] [Cited by in F6Publishing: 57] [Article Influence: 4.0] [Reference Citation Analysis]
173 Hoppmann N, Massoud O. Medical care of liver transplant patients. Expert Rev Gastroenterol Hepatol 2020;14:901-18. [PMID: 32684007 DOI: 10.1080/17474124.2020.1797483] [Reference Citation Analysis]
174 Karasu Z, Ulukaya S, Ayanoglu HO, Basturk B, Ulukaya E, Akyildiz M, Tokat Y. Cytokine gene polymorphism and early graft rejection in liver transplant recipients. Transplant Proc. 2004;36:2791-2795. [PMID: 15621151 DOI: 10.1016/j.transproceed.2004.10.034] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
175 Couto CA, Bittencourt PL, Farias AQ, Lallee MP, Cançado EL, Massarollo PC, Mies S. Human polyclonal anti-hepatitis B surface antigen immunoglobulin reduces the frequency of acute rejection after liver transplantation for chronic hepatitis B. Rev Inst Med Trop Sao Paulo 2001;43:335-7. [PMID: 11781604 DOI: 10.1590/s0036-46652001000600007] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
176 Burton JR, Rosen HR. Diagnosis and Management of Allograft Failure. Clinics in Liver Disease 2006;10:407-35. [DOI: 10.1016/j.cld.2006.05.003] [Cited by in Crossref: 26] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
177 Levitsky J, Goldberg D, Smith AR, Mansfield SA, Gillespie BW, Merion RM, Lok AS, Levy G, Kulik L, Abecassis M, Shaked A. Acute Rejection Increases Risk of Graft Failure and Death in Recent Liver Transplant Recipients. Clin Gastroenterol Hepatol 2017; 15: 584-593. e2. [PMID: 27567694 DOI: 10.1016/j.cgh.2016.07.035] [Cited by in Crossref: 81] [Cited by in F6Publishing: 70] [Article Influence: 13.5] [Reference Citation Analysis]
178 Czaja AJ. Autoimmune hepatitis after liver transplantation and other lessons of self-intolerance. Liver Transpl. 2002;8:505-513. [PMID: 12037780 DOI: 10.1053/jlts.2002.33485] [Cited by in Crossref: 78] [Cited by in F6Publishing: 66] [Article Influence: 3.9] [Reference Citation Analysis]
179 Cabrera R, Ararat M, Soldevila-Pico C, Dixon L, Pan JJ, Firpi R, Machicao V, Levy C, Nelson D, Morelli G. Using an immune functional assay to differentiate acute cellular rejection from recurrent hepatitis C in liver transplant patients. Liver Transpl. 2009;15:216-222. [PMID: 19177434 DOI: 10.1002/lt.21666] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 3.4] [Reference Citation Analysis]
180 Te HS, Baker AL. INTRAHEPATIC CHOLESTASIS FOLLOWING LIVER TRANSPLANTATION. Clinics in Liver Disease 1999;3:633-49. [DOI: 10.1016/s1089-3261(05)70088-x] [Cited by in Crossref: 3] [Article Influence: 0.1] [Reference Citation Analysis]
181 Grotelueschen R, Fischer L, Rogiers X. The use of induction agents in liver transplantation. Current Opinion in Organ Transplantation 2006;11:627-31. [DOI: 10.1097/mot.0b013e328010c522] [Reference Citation Analysis]
182 Bloom RD, Goldberg LR, Wang AY, Faust TW, Kotloff RM. An Overview of Solid Organ Transplantation. Clinics in Chest Medicine 2005;26:529-43. [DOI: 10.1016/j.ccm.2005.06.002] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
183 Thomson AW, Vionnet J, Sanchez-Fueyo A. Understanding, predicting and achieving liver transplant tolerance: from bench to bedside. Nat Rev Gastroenterol Hepatol 2020;17:719-39. [PMID: 32759983 DOI: 10.1038/s41575-020-0334-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
184 Czaja AJ, Manns MP. Advances in the diagnosis, pathogenesis, and management of autoimmune hepatitis. Gastroenterology. 2010;139:58-72.e4. [PMID: 20451521 DOI: 10.1053/j.gastro.2010.04.053] [Cited by in Crossref: 184] [Cited by in F6Publishing: 165] [Article Influence: 15.3] [Reference Citation Analysis]
185 Kok B, Dong V, Karvellas CJ. Graft Dysfunction and Management in Liver Transplantation. Crit Care Clin 2019;35:117-33. [PMID: 30447775 DOI: 10.1016/j.ccc.2018.08.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
186 Neumann UP, Langrehr JM, Lang M, Schmitz V, Menzel S, Steinmueller T, Neuhaus P. Impact of HLA matching upon outcome after liver transplantation. Transplant Proc 2002;34:1499-500. [PMID: 12176456 DOI: 10.1016/s0041-1345(02)02946-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
187 Boix F, Bolarín JM, Mrowiec A, Eguía J, Gonzalez-Martinez G, de la Peña J, Galian JA, Alfaro R, Moya-Quiles MR, Legaz I, Campillo JA, Ramírez P, García-Alonso A, Pons JA, Sánchez-Bueno F, Minguela A, Llorente S, Muro M. CD28 biomarker quantification and expression level profiles in CD4+ T-lymphocytes in solid organ transplantation. Transpl Immunol 2017;42:9-17. [PMID: 28392336 DOI: 10.1016/j.trim.2017.04.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
188 Furukawa H, Todo S. Evolution of immunosuppression in liver transplantation: contribution of cyclosporine. Transplantation Proceedings 2004;36:S274-84. [DOI: 10.1016/j.transproceed.2004.01.023] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
189 Perry I, Neuberger J. Immunosuppression: towards a logical approach in liver transplantation. Clin Exp Immunol. 2005;139:2-10. [PMID: 15606606 DOI: 10.1111/j.1365-2249.2005.02662.x] [Cited by in Crossref: 52] [Cited by in F6Publishing: 46] [Article Influence: 3.1] [Reference Citation Analysis]
190 Graziadei IW, Wiesner RH, Marotta PJ, Porayko MK, Hay JE, Charlton MR, Poterucha JJ, Rosen CB, Gores GJ, LaRusso NF. Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis. Hepatology. 1999;30:1121-1127. [PMID: 10534330 DOI: 10.1002/hep.510300501] [Cited by in Crossref: 255] [Cited by in F6Publishing: 202] [Article Influence: 11.1] [Reference Citation Analysis]
191 Gane E. Liver Transplantation for Chronic Hepatitis B and C. In: Thomas HC, Lok AS, Locarnini SA, Zuckerman AJ, editors. Viral Hepatitis. Oxford: John Wiley & Sons, Ltd; 2013. pp. 203-17. [DOI: 10.1002/9781118637272.ch15] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
192 Schmuck RB, Reutzel-selke A, Raschzok N, Morgul HM, Struecker B, Lippert S, de Carvalho Fischer C, Schmelzle M, Boas-knoop S, Bahra M, Pascher A, Pratschke J, Sauer IM. Bile: miRNA pattern and protein-based biomarkers may predict acute cellular rejection after liver transplantation. Biomarkers 2016;22:19-27. [DOI: 10.1080/1354750x.2016.1201538] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
193 Sato K, Sekiguchi S, Kawagishi N, Akamatsu Y, Ishida K, Fukushima D, Miyagi S, Takeda I, Yamaguchi M, Oguma S, Fujimori K, Sato A, Satomi S. Unique histopathological features of graft biopsies with liver function abnormalities in living donor liver transplant patients receiving basiliximab induction therapy: Unique histopathological features after LDLT. Clinical Transplantation 2011;25:61-8. [DOI: 10.1111/j.1399-0012.2010.01219.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
194 Baron D, Giral M, Brouard S. Reconsidering the detection of tolerance to individualize immunosuppression minimization and to improve long-term kidney graft outcomes. Transpl Int 2015;28:938-59. [DOI: 10.1111/tri.12578] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
195 Sugawara Y. Positive T lymphocytotoxic cross-match in living donor liver transplantation. Liver Transplantation 2003;9:1062-6. [DOI: 10.1053/jlts.2003.50209] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
196 Jiang YZ, Zhou GP, Wu SS, Kong YY, Zhu ZJ, Sun LY. Safety and efficacy of liver transplantation for methylmalonic acidemia: A systematic review and meta-analysis. Transplant Rev (Orlando) 2021;35:100592. [PMID: 33422927 DOI: 10.1016/j.trre.2020.100592] [Reference Citation Analysis]
197 Ravaioli M, Cucchetti A, Pinna AD, De Pace V, Neri F, Barbera MA, Maroni L, Frega G, Palloni A, De Lorenzo S, Ripoli MC, Pantaleo MA, Cescon M, Del Gaudio M, Brandi G. The role of metronomic capecitabine for treatment of recurrent hepatocellular carcinoma after liver transplantation. Sci Rep 2017;7:11305. [PMID: 28900245 DOI: 10.1038/s41598-017-11810-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
198 Mittal C, Qureshi W, Singla S, Ahmad U, Huang MA. Pre-transplant left ventricular diastolic dysfunction is associated with post transplant acute graft rejection and graft failure. Dig Dis Sci. 2014;59:674-680. [PMID: 24323177 DOI: 10.1007/s10620-013-2955-8] [Cited by in Crossref: 35] [Cited by in F6Publishing: 26] [Article Influence: 3.9] [Reference Citation Analysis]
199 Blanco-García RM, López-Álvarez MR, Garrido IP, Salgado-Cecilia G, Campillo JA, Bolarín JM, Legaz I, Muro M, García-Alonso AM, Martínez-Sánchez MV, Moral JM, Pascual-Figal DA, Alvarez-López MR, Miras M, Minguela A. CD28 and KIR2D receptors as sensors of the immune status in heart and liver transplantation. Hum Immunol 2011;72:841-8. [PMID: 21742001 DOI: 10.1016/j.humimm.2011.06.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
200 Pleguezuelo M, Germani G, Burroughs AK. Liver Transplantation: Prevention and Treatment of Rejection. In: Mcdonald JW, Burroughs AK, Feagan BG, Fennerty MB, editors. Evidence‐Based Gastroenterology and Hepatology. Wiley; 2010. pp. 685-723. [DOI: 10.1002/9781444314403.ch42] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
201 Pageaux GP, Calmus Y, Boillot O, Ducerf C, Vanlemmens C, Boudjema K, Samuel D; French CHI-F-01 Study Group. Steroid withdrawal at day 14 after liver transplantation: a double-blind, placebo-controlled study. Liver Transpl 2004;10:1454-60. [PMID: 15558584 DOI: 10.1002/lt.20291] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 2.4] [Reference Citation Analysis]
202 Gupta P, Hart J, Cronin D, Kelly S, Michael Millis J, Brady L. RISK FACTORS FOR CHRONIC REJECTION AFTER PEDIATRIC LIVER TRANSPLANTATION: . Transplantation 2001;72:1098-102. [DOI: 10.1097/00007890-200109270-00020] [Cited by in Crossref: 76] [Cited by in F6Publishing: 61] [Article Influence: 3.6] [Reference Citation Analysis]
203 McDiarmid SV. Liver transplantation. The pediatric challenge. Clin Liver Dis 2000;4:879-927. [PMID: 11232362 DOI: 10.1016/s1089-3261(05)70146-x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
204 Deng YL, Xiong XZ, Cheng NS. Efficacy of ursodeoxycholic acid as an adjuvant treatment to prevent acute cellular rejection after liver transplantation: a meta-analysis of randomized controlled trials. Hepatobiliary Pancreat Dis Int 2014;13:464-73. [PMID: 25308356 DOI: 10.1016/s1499-3872(14)60260-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
205 Ben-Ari Z, Pappo O, Mor E. Intrahepatic cholestasis after liver transplantation. Liver Transpl 2003;9:1005-18. [PMID: 14526393 DOI: 10.1053/jlts.2003.50212] [Cited by in Crossref: 67] [Cited by in F6Publishing: 47] [Article Influence: 3.7] [Reference Citation Analysis]
206 Hashimoto K, Miller C. The use of marginal grafts in liver transplantation. J Hepatobiliary Pancreat Surg 2008;15:92-101. [DOI: 10.1007/s00534-007-1300-z] [Cited by in Crossref: 40] [Cited by in F6Publishing: 29] [Article Influence: 2.9] [Reference Citation Analysis]
207 Fosby B, Næss S, Hov JR, Traherne J, Boberg KM, Trowsdale J, Foss A, Line PD, Franke A, Melum E, Scott H, Karlsen TH. HLA variants related to primary sclerosing cholangitis influence rejection after liver transplantation. World J Gastroenterol 2014; 20(14): 3986-4000 [PMID: 24744588 DOI: 10.3748/wjg.v20.i14.3986] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
208 Matinlauri I, Nurminen M, Höckerstedt K, Isoniemi H. Changes in Liver Graft Rejections Over Time. Transplantation Proceedings 2006;38:2663-6. [DOI: 10.1016/j.transproceed.2006.07.032] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
209 Morgul MH, Splith K, Leonhardt C, Raschzok N, Reutzel-Selke A, Schmuck RB, Andreou A, Atanasov G, Benzing C, Krenzien F, Hau HM, Felgendreff P, Klunk S, Pratschke J, Sauer IM, Schmelzle M. The value of microparticles in detecting acute rejection episodes after liver transplantation. Biomarkers 2018;23:25-32. [PMID: 28303731 DOI: 10.1080/1354750X.2017.1306754] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
210 Schmitt TM, Phillips M, Sawyer RG, Northup P, Hagspiel KD, Pruett TL, Bonatti HJ. Anti-thymocyte globulin for the treatment of acute cellular rejection following liver transplantation. Dig Dis Sci. 2010;55:3224-3234. [PMID: 20238251 DOI: 10.1007/s10620-010-1149-x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
211 Sabra TA, Okajima H, Yoshizawa A, Ogawa E, Okamoto S, Osman MA, Saad-Eldin Y, Uemoto S. Early post-operative intravenous tacrolimus in pediatric liver transplant recipients is not superior to oral tacrolimus. Pediatr Transplant 2019;23:e13368. [PMID: 30719833 DOI: 10.1111/petr.13368] [Reference Citation Analysis]
212 Rodríguez-perálvarez M, Rico-juri JM, Tsochatzis E, Burra P, De la Mata M, Lerut J. Biopsy-proven acute cellular rejection as an efficacy endpoint of randomized trials in liver transplantation: a systematic review and critical appraisal. Transpl Int 2016;29:961-73. [DOI: 10.1111/tri.12737] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 3.5] [Reference Citation Analysis]
213 Chi XL, Xiao HM, Xie YB, Cai GS, Jiang JM, Tian GJ, Shi MJ, Wu SD, Zhao PT, Chen HJ. Protocol of a prospective study for the combination treatment of Shu-Gan-jian-Pi decoction and steroid standard therapy in autoimmune hepatitis patients. BMC Complement Altern Med 2016;16:505. [PMID: 27923369 DOI: 10.1186/s12906-016-1486-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
214 Lo RC, Chan KK, Leung CO, Ng IO. Expression of hepatic progenitor cell markers in acute cellular rejection of liver allografts-An immunohistochemical study. Clin Transplant 2018;32:e13203. [PMID: 29345755 DOI: 10.1111/ctr.13203] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
215 Rodríguez-Perálvarez M, García-Caparrós C, Tsochatzis E, Germani G, Hogan B, Poyato-González A, O’Beirne J, Senzolo M, Guerrero-Misas M, Montero-Álvarez JL. Lack of agreement for defining ‘clinical suspicion of rejection’ in liver transplantation: a model to select candidates for liver biopsy. Transpl Int. 2015;28:455-464. [PMID: 25557691 DOI: 10.1111/tri.12514] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
216 Sahni VA, Raghunathan G, Mearadji B, Ukomadu C, Glickman J, Silverman SG, Erturk SM, Mortele KJ. Autoimmune hepatitis: CT and MR imaging features with histopathological correlation. Abdom Imaging. 2010;35:75-84. [PMID: 19067033 DOI: 10.1007/s00261-008-9485-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
217 Nair S, Eustace J, Thuluvath PJ. Effect of race on outcome of orthotopic liver transplantation: a cohort study. The Lancet 2002;359:287-93. [DOI: 10.1016/s0140-6736(02)07494-9] [Cited by in Crossref: 120] [Cited by in F6Publishing: 30] [Article Influence: 6.0] [Reference Citation Analysis]
218 Christen U, Holdener M, Hintermann E. Animal models for autoimmune hepatitis. Autoimmunity Reviews 2007;6:306-11. [DOI: 10.1016/j.autrev.2006.04.001] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 1.6] [Reference Citation Analysis]
219 Uemura T, Ikegami T, Sanchez EQ, Jennings LW, Narasimhan G, McKenna GJ, Randall HB, Chinnakotla S, Levy MF, Goldstein RM. Late acute rejection after liver transplantation impacts patient survival. Clin Transplant. 2008;22:316-323. [PMID: 18190550 DOI: 10.1111/j.1399-0012.2007.00788.x] [Cited by in Crossref: 58] [Cited by in F6Publishing: 47] [Article Influence: 4.1] [Reference Citation Analysis]
220 Shepard PW, St Louis EK. Seizure treatment in transplant patients. Curr Treat Options Neurol. 2012;14:332-347. [PMID: 22660960 DOI: 10.1007/s11940-012-0180-y] [Cited by in Crossref: 31] [Cited by in F6Publishing: 21] [Article Influence: 3.1] [Reference Citation Analysis]
221 Bathgate AJ, Pravica V, Perrey C, Therapondos G, Plevris JN, Hayes PC, Hutchinson IV. The effect of polymorphisms in tumor necrosis factor-alpha, interleukin-10, and transforming growth factor-beta1 genes in acute hepatic allograft rejection. Transplantation. 2000;69:1514-1517. [PMID: 10798783 DOI: 10.1097/00007890-200004150-00054] [Cited by in Crossref: 80] [Cited by in F6Publishing: 79] [Article Influence: 3.6] [Reference Citation Analysis]
222 O'Grady J. C(2) monitoring: out of the blocks but with some way to go! Transplantation 2004;77:1639. [PMID: 15201659 DOI: 10.1097/00007890-200406150-00003] [Reference Citation Analysis]
223 McTaggart RA, Terrault NA, Vardanian AJ, Bostrom A, Feng S. Hepatitis C etiology of liver disease is strongly associated with early acute rejection following liver transplantation. Liver Transpl. 2004;10:975-985. [PMID: 15390322 DOI: 10.1002/lt.20213] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 2.3] [Reference Citation Analysis]
224 Schuller S, Wiederkehr JC, Coelho-Lemos IM, Avilla SG, Schultz C. Daclizumab induction therapy associated with tacrolimus-MMF has better outcome compared with tacrolimus-MMF alone in pediatric living donor liver transplantation. Transplant Proc. 2005;37:1151-1152. [PMID: 15848653 DOI: 10.1016/j.transproceed.2005.01.023] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
225 Kubal CA. The authors' reply. Transplantation 2014;97:e62. [PMID: 24827897 DOI: 10.1097/TP.0000000000000147] [Reference Citation Analysis]
226 Shin E, Kim JH, Yu E. Histopathological causes of late liver allograft dysfunction: analysis at a single institution. Korean J Pathol 2013;47:21-7. [PMID: 23483073 DOI: 10.4132/KoreanJPathol.2013.47.1.21] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
227 Dedmon M. Liver transplantation Managing complications in primary care: . Journal of the American Academy of Physician Assistants 2005;18:41-9. [DOI: 10.1097/01720610-200502000-00007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
228 Fusai G, Dhaliwal P, Rolando N, Sabin CA, Patch D, Davidson BR, Burroughs AK, Rolles K. Incidence and risk factors for the development of prolonged and severe intrahepatic cholestasis after liver transplantation. Liver Transpl 2006;12:1626-33. [PMID: 16952166 DOI: 10.1002/lt.20870] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
229 Levitsky J, Feng S. Tolerance in clinical liver transplantation. Hum Immunol. 2018;79:283-287. [PMID: 29054397 DOI: 10.1016/j.humimm.2017.10.007] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 9.4] [Reference Citation Analysis]
230 Jain A, Demetris AJ, Kashyap R, Blakomer K, Ruppert K, Khan A, Rohal S, Starzl TE, Fung JJ. Does tacrolimus offer virtual freedom from chronic rejection after primary liver transplantation? Risk and prognostic factors in 1,048 liver transplantations with a mean follow-up of 6 years. Liver Transpl. 2001;7:623-630. [PMID: 11460230 DOI: 10.1053/jlts.2001.25364] [Cited by in Crossref: 63] [Cited by in F6Publishing: 46] [Article Influence: 3.0] [Reference Citation Analysis]
231 González JT, Bellido CB, Riera GJ, Marente VC, Gómez LM, Artacho GS, Martínez JÁ, Díez-canedo JS, Ruíz RP, Bravo MG. Study of Liver Transplant Rejection in Alcoholism-Induced Cirrhosis. Transplantation Proceedings 2013;45:3650-2. [DOI: 10.1016/j.transproceed.2013.10.023] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
232 Oertel M, Kohlhaw K, Diepolder HM, Schr??der S, Schwarz R, Tannapfel A, M??ssner J, Hauss J, Berr F. ALLOREACTIVITY OF NATURAL KILLER CELLS IN ALLOGENEIC LIVER TRANSPLANTATION1,2: . Transplantation 2001;72:116-22. [DOI: 10.1097/00007890-200107150-00023] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 1.5] [Reference Citation Analysis]
233 Lim LL, Scarborough JD, Thorne JE, Graham E, Kempen JH, Mackensen F, Nguyen QD, Prabriputaloong T, Read RW, Suhler EB, Schwartz JM, Smith JR. Uveitis in Patients with Autoimmune Hepatitis. American Journal of Ophthalmology 2009;147:332-338.e1. [DOI: 10.1016/j.ajo.2008.08.019] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
234 Trotter JF, O'Grady J. Operational tolerance after liver transplantation: raising the bar or tripping up? Am J Transplant. 2010;10:2193-2194. [PMID: 20840484 DOI: 10.1111/j.1600-6143.2010.03252.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
235 Han JW, Joo DJ, Kim JH, Rha MS, Koh JY, Park HJ, Lee JG, Kim MS, Kim SI, Shin EC, Park JY, Park SH. Early reduction of regulatory T cells is associated with acute rejection in liver transplantation under tacrolimus-based immunosuppression with basiliximab induction. Am J Transplant 2020;20:2058-69. [PMID: 31965710 DOI: 10.1111/ajt.15789] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
236 Xu M, Tan C, Hu J, Alwahsh SM, Yan J, Hu J, Dai Z, Wang Z, Zhou J, Fan J, Huang X. Expression of hemopexin in acute rejection of rat liver allograft identified by serum proteomic analysis. Shock 2014;42:65-74. [PMID: 24667618 DOI: 10.1097/SHK.0000000000000171] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
237 Kao TL, Chen YL, Kuan YP, Chang WC, Ho YC, Yeh S, Jeng LB, Ma WL. Estrogen-Estrogen Receptor α Signaling Facilitates Bilirubin Metabolism in Regenerating Liver Through Regulating Cytochrome P450 2A6 Expression. Cell Transplant 2017;26:1822-9. [PMID: 29338386 DOI: 10.1177/0963689717738258] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
238 Song SH, Kim MS, Lee JJ, Ju MK, Lee JG, Lee J, Choi JS, Choi GH, Kim SI, Joo DJ. Effect of donor-specific antibodies and panel reactive antibodies in living donor liver transplant recipients. Ann Surg Treat Res 2015;88:100-5. [PMID: 25692121 DOI: 10.4174/astr.2015.88.2.100] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
239 Sellers MT, Mcguire BM, Haustein SV, Bynon JS, Hunt SL, Eckhoff DE. Two-dose Daclizumab Induction Therapy in 209 Liver Transplants: A Single-Center Analysis. Transplantation 2004;78:1212-7. [DOI: 10.1097/01.tp.0000138100.72757.ba] [Cited by in Crossref: 24] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
240 Åberg F, Isoniemi H, Höckerstedt K. Long-term results of liver transplantation. Scand J Surg 2011;100:14-21. [PMID: 21482501 DOI: 10.1177/145749691110000104] [Cited by in Crossref: 53] [Cited by in F6Publishing: 51] [Article Influence: 4.8] [Reference Citation Analysis]
241 Ali MA, Elshobari MM, Salah T, Kandeel AR, Sultan AM, Elghawalby AN, Shehta A, Elsayed U, Fathy O, Yassen A, Wahab MA. Impact of donor-recipient genetic relationship on outcome of living donor liver transplantation. Liver Transpl 2017;23:43-9. [PMID: 27516392 DOI: 10.1002/lt.24599] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
242 Corbani A, Burroughs AK. Intrahepatic cholestasis after liver transplantation. Clin Liver Dis 2008;12:111-29, ix. [PMID: 18242500 DOI: 10.1016/j.cld.2007.11.001] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
243 Milkiewicz P, Gunson B, Saksena S, Hathaway M, Hubscher SG, Elias E. INCREASED INCIDENCE OF CHRONIC REJECTION IN ADULT PATIENTS TRANSPLANTED FOR AUTOIMMUNE HEPATITIS: ASSESSMENT OF RISK FACTORS1: . Transplantation 2000;70:477-80. [DOI: 10.1097/00007890-200008150-00014] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 1.8] [Reference Citation Analysis]
244 Francque S, Vonghia L, Ramon A, Michielsen P. Epidemiology and treatment of autoimmune hepatitis. Hepat Med. 2012;4:1-10. [PMID: 24367228 DOI: 10.2147/hmer.s16321] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
245 Schreibman I, Gaynor JJ, Jayaweera D, Pyrsopoulos N, Weppler D, Tzakis A, Schiff ER, Regev A. Outcomes after orthotopic liver transplantation in 15 HIV-infected patients. Transplantation. 2007;84:697-705. [PMID: 17893602 DOI: 10.1097/01.tp.0000282873.24648.5b] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 2.6] [Reference Citation Analysis]
246 Langers P, Cremers SC, den Hartigh J, Veenendaal RA, ten Hove WR, Ringers J, Lamers CB, van Hoek B. Switching monitoring of emulsified cyclosporine from trough level to 2-hour level in stable liver transplant patients: Switching Cyclosporine C-0 to C-2 Monitoring in Liver Transplantation. Liver Transpl 2004;10:183-9. [DOI: 10.1002/lt.20056] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]
247 Massoud O, Heimbach J, Viker K, Krishnan A, Poterucha J, Sanchez W, Watt K, Wiesner R, Charlton M. Noninvasive diagnosis of acute cellular rejection in liver transplant recipients: a proteomic signature validated by enzyme-linked immunosorbent assay. Liver Transpl 2011;17:723-32. [PMID: 21618694 DOI: 10.1002/lt.22266] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 2.5] [Reference Citation Analysis]
248 Kim KR, Ko GY, Sung KB, Yoon HK, Shin JH, Song HY, Ryu JH, Hwang S, Lee SG, Yu E. Transjugular liver biopsy in patients with living donor liver transplantation: comparison with percutaneous biopsy. Liver Transpl 2008;14:971-9. [PMID: 18581512 DOI: 10.1002/lt.21448] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
249 Pravisani R, Hidaka M, Baccarani U, Hanada M, Hara T, Kugiyama T, Hamada T, Eguchi S. Frailty Is Associated With Increased Rates of Acute Cellular Rejection Within 3 Months After Liver Transplantation. Liver Transpl 2020;26:1200-1. [PMID: 32291911 DOI: 10.1002/lt.25777] [Reference Citation Analysis]
250 Ramirez CB, Doria C, di Francesco F, Iaria M, Kang Y, Marino IR. Anti-IL2 Induction in Liver Transplantation with 93% Rejection-Free Patient and Graft Survival at 18 Months. Journal of Surgical Research 2007;138:198-204. [DOI: 10.1016/j.jss.2006.08.025] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
251 Ostojic A, Markotic A, Kelava T, Mrzljak A. Association between CXCL9/10 polymorphisms and acute rejection of liver allograft. Medicine (Baltimore) 2019;98:e14612. [PMID: 30813187 DOI: 10.1097/MD.0000000000014612] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
252 Sawada T, Shimizu A, Kubota K, Fuchinoue S, Teraoka S. Lobular damage caused by cellular and humoral immunity in liver allograft rejection. Clin Transplant 2005;19:110-4. [PMID: 15659143 DOI: 10.1111/j.1399-0012.2004.00310.x] [Cited by in Crossref: 47] [Cited by in F6Publishing: 44] [Article Influence: 2.8] [Reference Citation Analysis]
253 Neumann UP, Guckelberger O, Langrehr JM, Lang M, Schmitz V, Theruvath T, Schonemann C, Menzel S, Klupp J, Neuhaus P. Impact of human leukocyte antigen matching in liver transplantation. Transplantation. 2003;75:132-137. [PMID: 12544885 DOI: 10.1097/00007890-200301150-00024] [Cited by in Crossref: 47] [Cited by in F6Publishing: 33] [Article Influence: 2.5] [Reference Citation Analysis]
254 Malik SM, Devera ME, Fontes P, Shaikh O, Sasatomi E, Ahmad J. Recurrent disease following liver transplantation for nonalcoholic steatohepatitis cirrhosis. Liver Transpl. 2009;15:1843-1851. [PMID: 19938117 DOI: 10.1002/lt.21943] [Cited by in Crossref: 80] [Cited by in F6Publishing: 62] [Article Influence: 6.7] [Reference Citation Analysis]
255 Poupon R. Autoimmune overlapping syndromes. Clin Liver Dis. 2003;7:865-878. [PMID: 14594134 DOI: 10.1016/s1089-3261(03)00092-8] [Cited by in Crossref: 47] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
256 Vitale G, Gitto S, Campani C, Turco L, Baldan A, Marra F, Morelli MC. Biological therapies in patients with liver disease: are they really lifesavers? Expert Opin Biol Ther 2021;:1-18. [PMID: 34860629 DOI: 10.1080/14712598.2022.2013799] [Reference Citation Analysis]
257 Liu F, Li B, Wang WT, Wei YG, Yan LN, Wen TF, Xu MQ, Yang JY. Interleukin-10-1082G/A polymorphism and acute liver graft rejection: A meta-analysis. World J Gastroenterol 2012; 18(8): 847-854 [PMID: 22371646 DOI: 10.3748/wjg.v18.i8.847] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
258 Alexander J, Chu W, Swanson PE, Yeh MM. The significance of plasma cell infiltrate in acute cellular rejection of liver allografts. Hum Pathol 2012;43:1645-50. [PMID: 22436628 DOI: 10.1016/j.humpath.2011.12.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
259 Eckhoff DE, McGuire B, Sellers M, Contreras J, Frenette L, Young C, Hudson S, Bynon JS. The safety and efficacy of a two-dose daclizumab (zenapax) induction therapy in liver transplant recipients. Transplantation. 2000;69:1867-1872. [PMID: 10830224 DOI: 10.1097/00007890-200005150-00022] [Cited by in Crossref: 89] [Cited by in F6Publishing: 71] [Article Influence: 4.0] [Reference Citation Analysis]
260 Wadström J, Ericzon BG, Halloran PF, Bechstein WO, Opelz G, Serón D, Grinyó J, Loupy A, Kuypers D, Mariat C, Clancy M, Jardine AG, Guirado L, Fellström B, O'Grady J, Pirenne J, O'Leary JG, Aluvihare V, Trunečka P, Baccarani U, Neuberger J, Soto-Gutierrez A, Geissler EK, Metzger M, Gray M. Advancing Transplantation: New Questions, New Possibilities in Kidney and Liver Transplantation. Transplantation 2017;101 Suppl 2S:S1-S41. [PMID: 28125449 DOI: 10.1097/TP.0000000000001563] [Cited by in Crossref: 15] [Cited by in F6Publishing: 4] [Article Influence: 3.8] [Reference Citation Analysis]
261 Langers P, Cremers SC, den Hartigh J, Rijnbeek EM, Ringers J, Lamers CB, van Hoek B. Easy-to-use, accurate and flexible individualized Bayesian limited sampling method without fixed time points for ciclosporin monitoring after liver transplantation. Aliment Pharmacol Ther 2005;21:549-57. [PMID: 15740538 DOI: 10.1111/j.1365-2036.2005.02364.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
262 Blakolmer K, Jain A, Ruppert K, Gray E, Duquesnoy R, Murase N, Starzl TE, Fung JJ, Demetris AJ. Chronic liver allograft rejection in a population treated primarily with tacrolimus as baseline immunosuppression: long-term follow-up and evaluation of features for histopathological staging. Transplantation. 2000;69:2330-2336. [PMID: 10868635 DOI: 10.1097/00007890-200006150-00019] [Cited by in Crossref: 58] [Cited by in F6Publishing: 43] [Article Influence: 2.6] [Reference Citation Analysis]
263 Neil DA, Hubscher SG. Histologic and biochemical changes during the evolution of chronic rejection of liver allografts. Hepatology. 2002;35:639-651. [PMID: 11870379 DOI: 10.1053/jhep.2002.31726] [Cited by in Crossref: 69] [Cited by in F6Publishing: 55] [Article Influence: 3.5] [Reference Citation Analysis]
264 Oertel M, Sack U, Kohlhaw K, Lehmann I, Emmrich F, Berr F, Hauss J, Schwarz R. Induction therapy including antithymocyte globulin induces marked alterations in T lymphocyte subpopulations after liver transplantation: results of a long-term study. Transplant Int 2002;15:463-71. [DOI: 10.1111/j.1432-2277.2002.tb00201.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
265 Neuberger JM, Bechstein WO, Kuypers DR, Burra P, Citterio F, De Geest S, Duvoux C, Jardine AG, Kamar N, Krämer BK, Metselaar HJ, Nevens F, Pirenne J, Rodríguez-Perálvarez ML, Samuel D, Schneeberger S, Serón D, Trunečka P, Tisone G, van Gelder T. Practical Recommendations for Long-term Management of Modifiable Risks in Kidney and Liver Transplant Recipients: A Guidance Report and Clinical Checklist by the Consensus on Managing Modifiable Risk in Transplantation (COMMIT) Group. Transplantation 2017;101:S1-S56. [PMID: 28328734 DOI: 10.1097/TP.0000000000001651] [Cited by in Crossref: 114] [Cited by in F6Publishing: 43] [Article Influence: 22.8] [Reference Citation Analysis]
266 Taner T. Liver transplantation: Rejection and tolerance: TANER. Liver Transpl 2017;23:S85-8. [DOI: 10.1002/lt.24840] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
267 Fozouni L, Mohamad Y, Lebsack A, Freise C, Stock P, Lai JC. Frailty Is Associated With Increased Rates of Acute Cellular Rejection Within 3 Months After Liver Transplantation. Liver Transpl 2020;26:390-6. [PMID: 31655014 DOI: 10.1002/lt.25669] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
268 Czaja AJ. Current and future treatments of autoimmune hepatitis. Expert Rev Gastroenterol Hepatol. 2009;3:269-291. [PMID: 19485809 DOI: 10.1586/egh.09.15] [Cited by in Crossref: 44] [Cited by in F6Publishing: 42] [Article Influence: 3.4] [Reference Citation Analysis]
269 Fairfield C, Penninga L, Powell J, Harrison EM, Wigmore SJ. Glucocorticosteroid-free versus glucocorticosteroid-containing immunosuppression for liver transplanted patients. Cochrane Database Syst Rev. 2015;CD007606. [PMID: 26666504 DOI: 10.1002/14651858.cd007606.pub3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
270 Shepherd RW, Turmelle Y, Nadler M, Lowell JA, Narkewicz MR, McDiarmid SV, Anand R, Song C. Risk factors for rejection and infection in pediatric liver transplantation. Am J Transplant. 2008;8:396-403. [PMID: 18162090 DOI: 10.1111/j.1600-6143.2007.02068.x] [Cited by in Crossref: 96] [Cited by in F6Publishing: 65] [Article Influence: 6.4] [Reference Citation Analysis]
271 Bishara A, Brautbar C, Zamir G, Eid A, Safadi R. Impact of HLA-C and Bw epitopes disparity on liver transplantation outcome. Hum Immunol. 2005;66:1099-1105. [PMID: 16571410 DOI: 10.1016/j.humimm.2005.10.016] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 1.6] [Reference Citation Analysis]
272 Mendizabal M, Marciano S, dos Santos Schraiber L, Zapata R, Quiros R, Zanotelli ML, Rivas MM, Kusminsky G, Humeres R, Alves de Mattos A, Gadano A, Silva MO. Post-transplant lymphoproliferative disorder in adult liver transplant recipients: a South American multicenter experience. Clin Transplant 2013;27:E469-77. [DOI: 10.1111/ctr.12152] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
273 Choi D, Liu M, Guttikonda D, Galen K, Guzman G, Jeon H, Aloman C. Recipient risk factors for acute cellular rejection after orthotopic liver transplant - a single-center, retrospective study. Transpl Int 2020;33:1779-87. [PMID: 32990344 DOI: 10.1111/tri.13756] [Reference Citation Analysis]
274 Levy G, Burra P, Cavallari A, Duvoux C, Lake J, Mayer AD, Mies S, Pollard SG, Varo E, Villamil F, Johnston A. Improved clinical outcomes for liver transplant recipients using cyclosporine monitoring based on 2-hr post-dose levels (C2)1: . Transplantation 2002;73:953-9. [DOI: 10.1097/00007890-200203270-00022] [Cited by in Crossref: 161] [Cited by in F6Publishing: 131] [Article Influence: 8.1] [Reference Citation Analysis]
275 Wei Q, Wang K, He Z, Ke Q, Xu X, Zheng S. Acute Liver Allograft Rejection After Living Donor Liver Transplantation: Risk Factors and Patient Survival. The American Journal of the Medical Sciences 2018;356:23-9. [DOI: 10.1016/j.amjms.2018.03.018] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
276 Wiesner RH, Batts KP, Krom RA. Evolving concepts in the diagnosis, pathogenesis, and treatment of chronic hepatic allograft rejection. Liver Transpl Surg. 1999;5:388-400. [PMID: 10477840 DOI: 10.1002/lt.500050519] [Cited by in Crossref: 74] [Cited by in F6Publishing: 51] [Article Influence: 3.2] [Reference Citation Analysis]
277 Demetris A, Adams D, Bellamy C, Blakolmer K, Clouston A, Dhillon AP, Fung J, Gouw A, Gustafsson B, Haga H, Harrison D, Hart J, Hubscher S, Jaffe R, Khettry U, Lassman C, Lewin K, Martinez O, Nakazawa Y, Neil D, Pappo O, Parizhskaya M, Randhawa P, Rasoul-Rockenschaub S, Reinholt F, Reynes M, Robert M, Tsamandas A, Wanless I, Wiesner R, Wernerson A, Wrba F, Wyatt J, Yamabe H. Update of the International Banff Schema for Liver Allograft Rejection: working recommendations for the histopathologic staging and reporting of chronic rejection. An International Panel. Hepatology. 2000;31:792-799. [PMID: 10706577 DOI: 10.1002/hep.510310337] [Cited by in Crossref: 377] [Cited by in F6Publishing: 309] [Article Influence: 17.1] [Reference Citation Analysis]
278 Zazzetti F, Buschiazzo A, Villamil F, Barreira J. Liver transplantation in systemic lupus erythematosus: case report and review of the literature. Lupus 2011;20:90-4. [DOI: 10.1177/0961203310377219] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
279 Demetris A, Nalesnik M, Randhawa P, Wu T, Minervini M, Lai C, Lu Z. Histological Patterns of Rejection and Other Causes of Liver Dysfunction. Transplantation of the Liver. Elsevier; 2005. pp. 1057-128. [DOI: 10.1016/b978-0-7216-0118-2.50074-4] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
280 Tovikkai C, Limsrichamrern S, Dumronggittigule W, Sirivatanauksorn Y, Kositamongkol P, Mahawithitwong P, Sangserestid P, Assawasirisin C. Delayed Calcineurin Inhibitor Introduction Without Antibody Induction in Liver Transplantation Is Safe and Helps Preserve Kidney Function. Transplant Proc 2021;53:645-8. [PMID: 33358420 DOI: 10.1016/j.transproceed.2020.11.005] [Reference Citation Analysis]
281 Lefkowitch JH. Diagnostic issues in liver transplantation pathology. Clinics in Liver Disease 2002;6:555-70. [DOI: 10.1016/s1089-3261(02)00003-x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
282 Oertel M, Berr F, Schröder S, Schwarz R, Tannapfel A, Wenzke M, Lamesch P, Hauss J, Kohlhaw K. Acute rejection of hepatic allografts from HLA-DR13 (Allele DRB1(*)1301)-positive donors. Liver Transpl 2000;6:728-33. [PMID: 11084059 DOI: 10.1053/jlts.2000.18480] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
283 Fosby B, Karlsen TH, Melum E. Recurrence and rejection in liver transplantation for primary sclerosing cholangitis. World J Gastroenterol 2012; 18(1): 1-15 [PMID: 22228965 DOI: 10.3748/wjg.v18.i1.1] [Cited by in CrossRef: 80] [Cited by in F6Publishing: 63] [Article Influence: 8.0] [Reference Citation Analysis]
284 Wiesner R, Rabkin J, Klintmalm G, McDiarmid S, Langnas A, Punch J, McMaster P, Kalayoglu M, Levy G, Freeman R. A randomized double-blind comparative study of mycophenolate mofetil and azathioprine in combination with cyclosporine and corticosteroids in primary liver transplant recipients. Liver Transpl. 2001;7:442-450. [PMID: 11349266 DOI: 10.1053/jlts.2001.23356] [Cited by in Crossref: 210] [Cited by in F6Publishing: 164] [Article Influence: 10.0] [Reference Citation Analysis]
285 Vilatoba M, Contreras JL, Eckhoff DE. New immunosuppressive strategies in liver transplantation: balancing efficacy and toxicity: . Current Opinion in Organ Transplantation 2003;8:139-45. [DOI: 10.1097/00075200-200306000-00002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
286 Mimuro J, Mizuta K, Kawano Y, Hishikawa S, Hamano A, Kashiwakura Y, Ishiwata A, Ohmori T, Madoiwa S, Kawarasaki H. Impact of acute cellular rejection on coagulation and fibrinolysis biomarkers within the immediate post-operative period in pediatric liver transplantation. Pediatr Transplant. 2010;14:369-376. [PMID: 19793340 DOI: 10.1111/j.1399-3046.2009.01248.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
287 Tischer S, Fontana RJ. Drug-drug interactions with oral anti-HCV agents and idiosyncratic hepatotoxicity in the liver transplant setting. J Hepatol 2014;60:872-84. [PMID: 24280292 DOI: 10.1016/j.jhep.2013.11.013] [Cited by in Crossref: 51] [Cited by in F6Publishing: 43] [Article Influence: 5.7] [Reference Citation Analysis]
288 Nagata S, Okano S, Yonemitsu Y, Nakagawa K, Tomita Y, Yoshikai Y, Shimada M, Maehara Y, Sueishi K. Critical Roles of Memory T Cells and Antidonor Immunoglobulin in Rejection of Allogeneic Bone Marrow Cells in Sensitized Recipient Mice: . Transplantation 2006;82:689-98. [DOI: 10.1097/01.tp.0000235589.66683.0e] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
289 Charlton MR. Roadmap for improving patient and graft survival in the next 10 years. Liver Transpl. 2016;22:71-78. [PMID: 27514705 DOI: 10.1002/lt.24602] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
290 Czaja AJ. Diagnosis, pathogenesis, and treatment of autoimmune hepatitis after liver transplantation. Dig Dis Sci. 2012;57:2248-2266. [PMID: 22562533 DOI: 10.1007/s10620-012-2179-3] [Cited by in Crossref: 65] [Cited by in F6Publishing: 55] [Article Influence: 6.5] [Reference Citation Analysis]
291 Banff Working Group on Liver Allograft Pathology. Importance of liver biopsy findings in immunosuppression management: biopsy monitoring and working criteria for patients with operational tolerance. Liver Transpl. 2012;18:1154-1170. [PMID: 22645090 DOI: 10.1002/lt.23481] [Cited by in Crossref: 78] [Cited by in F6Publishing: 63] [Article Influence: 8.7] [Reference Citation Analysis]
292 Cheng L, Tian F, Tang L, Wang S, Chen G, Duan G, Yan X. Local distribution analysis of cytotoxic molecules in liver allograft is helpful for the diagnosis of acute cellular rejection after orthotopic liver transplantation. Diagn Pathol 2012;7:148. [PMID: 23111143 DOI: 10.1186/1746-1596-7-148] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
293 Aby E, Jimenez MA, Grotts JF, Agopian V, French SW, Busuttil RW, Saab S. Diminishing Use of Liver Biopsy among Liver Transplant Recipients for Hepatitis C. J Clin Transl Hepatol 2017;5:197-202. [PMID: 28936400 DOI: 10.14218/JCTH.2016.00073] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
294 Rocca LG, Yawn BP, Wollan P, Kim WR. Management of patients with hepatitis C in a community population: diagnosis, discussions, and decisions to treat. Ann Fam Med 2004;2:116-24. [PMID: 15083850 DOI: 10.1370/afm.62] [Cited by in Crossref: 27] [Cited by in F6Publishing: 33] [Article Influence: 1.5] [Reference Citation Analysis]
295 Kallwitz ER, Cotler SJ. Care of the Liver Transplant Patient. Disease-a-Month 2008;54:486-507. [DOI: 10.1016/j.disamonth.2008.03.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
296 Benjamin MM, Dasher KJ, Trotter JF. A comparison of outcomes between OKT3 and antithymocyte globulin for treatment of steroid-resistant rejection in hepatitis C liver transplant recipients. Transplantation 2014;97:470-3. [PMID: 24142032 DOI: 10.1097/01.TP.0000435701.54019.98] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
297 Haugaa H, Thorgersen EB, Pharo A, Boberg KM, Foss A, Line PD, Sanengen T, Almaas R, Grindheim G, Waelgaard L, Pischke SE, Mollnes TE, Inge Tønnessen T. Inflammatory markers sampled by microdialysis catheters distinguish rejection from ischemia in liver grafts. Liver Transpl 2012;18:1421-9. [PMID: 22767413 DOI: 10.1002/lt.23503] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
298 Warlé MC, Metselaar HJ, Hop WC, Gyssens IC, Kap M, Kwekkeboom J, de Rave S, Zondervan PE, Ijzermans JN, Tilanus HW, Bouma GJ. Early differentiation between rejection and infection in liver transplant patients by serum and biliary cytokine patterns: . Transplantation 2003;75:146-51. [DOI: 10.1097/00007890-200301150-00026] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 1.2] [Reference Citation Analysis]
299 O’Grady JG, Burroughs A, Hardy P, Elbourne D, Truesdale A. Tacrolimus versus microemulsified ciclosporin in liver transplantation: the TMC randomised controlled trial. Lancet. 2002;360:1119-1125. [PMID: 12387959 DOI: 10.1016/s0140-6736(02)11196-2] [Cited by in Crossref: 188] [Cited by in F6Publishing: 28] [Article Influence: 9.4] [Reference Citation Analysis]
300 Choudhary NS, Saigal S, Bansal RK, Saraf N, Gautam D, Soin AS. Acute and Chronic Rejection After Liver Transplantation: What A Clinician Needs to Know. J Clin Exp Hepatol 2017;7:358-66. [PMID: 29234201 DOI: 10.1016/j.jceh.2017.10.003] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 6.2] [Reference Citation Analysis]